Other infectious diseases

AB1_OTHER_INFECTIONS

infectious disease: A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B99 Hospital discharge: ICD-9 — 136[8-9] Hospital discharge: ICD-8 — 1360[8-9] Cause of death: ICD-10 — B99 Cause of death: ICD-9 — 136[8-9] Cause of death: ICD-8 — 1360[8-9] 2 out of 7 registries used, show all original rules.	3755
4. Check minimum number of events None	3755
5. Include endpoints None	3755
6. Filter based on genotype QC (FinnGen only)	3196

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: B99-B99
Name in latin: Morbi infectiosi alii et non specificati

NAME	AB1_OTHER_INFECTIONS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B99
HD_ICD_9	136[8-9]
HD_ICD_8	1360[8-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B99
COD_ICD_9	136[8-9]
COD_ICD_8	1360[8-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other infectious diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30118	14298	15550
Only index persons	25362	12247	13115
Unadjusted period prevalence (%)
Whole population	0.42	0.41	0.43
Only index persons	0.48	0.45	0.50
Median age at first event (years)
Whole population	65.84	66.85	64.81
Only index persons	64.46	65.47	63.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3196	1534	1662
Unadjusted period prevalence (%)	0.66	0.54	0.76
Median age at first event (years)	62.24	57.16	66.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3315: Matched controls
33150

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B99

ICD-10 Finland

Other and unspecified infectious diseases

12245.8

307.7

3131

R50.9

ICD-10 Finland

Fever, unspecified

5.4

307.7

1210

3171

A49.9

ICD-10 Finland

Bacterial infection, unspecified

6.1

307.7

1084

2453

J01MA12

ATC

levofloxacin; systemic

3.3

204.6

1051

4083

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

186.6

1435

6932

A41.9

ICD-10 Finland

Sepsis, unspecified

5.6

161.2

324

626

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.2

150.7

736

2719

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

141.2

1985

12363

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.9

134.7

768

3080

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.9

132.5

212

326

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.7

127.6

208

326

127

Kela drug reimbursment

Transplant complication

9.9

127.6

149

157

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

125.9

1030

4945

J01MA14

ATC

moxifloxacin; systemic

3.4

124.0

513

1700

TK800

NOMESCO Finland

Hemodialysis

7.1

120.5

186

275

L04AA06

ATC

mycophenolic acid; systemic

8.0

117.3

163

214

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

11.1

112.7

121

113

C03CA01

ATC

furosemide; systemic

2.3

112.7

1466

8553

13609

ICD-8 Finland

Other and unspecified infective and parasitic diseases, Morbus infectiosus sive parasitarius NUD

+∞

106.8

102

ZX120

NOMESCO Finland

Intravenous

3.1

99.2

481

1740

J01MA02

ATC

ciprofloxacin; systemic

2.1

98.1

1565

9751

Z49.1

ICD-10 Finland

Extracorporeal dialysis

8.1

97.7

133

170

A11CC03

ATC

alfacalcidol; systemic

5.6

94.7

184

342

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.3

93.1

257

641

B03XA02

ATC

darbepoetin alfa; parenteral

5.7

91.2

176

325

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.2

90.9

256

648

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.9

89.0

201

427

JN4BD

NOMESCO Finland

Extensive body CT

2.8

87.8

501

1974

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.8

87.6

503

1989

N18.0

ICD-10 Finland

End-stage renal disease

8.5

84.0

110

134

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.7

83.4

198

438

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.5

80.2

303

938

A12AA04

ATC

calcium carbonate; oral

6.5

78.7

130

206

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

78.1

323

1058

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

77.5

538

2330

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

77.5

756

3812

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

77.4

1283

7917

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

76.2

871

4679

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.3

75.8

156

305

N02AA05

ATC

oxycodone; systemic

2.2

75.8

837

4433

H02AB06

ATC

prednisolone; systemic

2.0

75.7

1735

11937

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

75.7

385

1421

Z94.0

ICD-10 Finland

Kidney transplant status

8.7

75.4

113

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

9.9

75.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

74.6

756

3866

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.6

72.8

180

411

196

Kela drug reimbursment

Paricalcitol and cinacalcet

14.3

72.5

D70.82

ICD-10 Finland

Drug-induced neutropenia

6.8

71.8

113

170

J01DB01

ATC

cefalexin; oral

2.3

71.2

2781

22855

N18.8

ICD-10 Finland

Other chronic renal failure

4.7

70.8

168

371

L04AX01

ATC

azathioprine; systemic

4.0

70.8

214

569

A41.8

ICD-10 Finland

Other specified sepsis

5.2

69.2

146

292

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

10.0

68.8

L04AD01

ATC

ciclosporin; systemic

6.4

68.5

115

185

L04AA01

ATC

[U] ciclosporin

7.6

67.1

130

M04AA01

ATC

allopurinol; systemic

2.2

64.5

627

3132

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.3

64.3

170

409

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

63.4

1105

6831

A46

ICD-10 Finland

Erysipelas

2.2

63.4

642

3259

ZXD05

NOMESCO Finland

Urgent procedure

1.9

62.9

1124

7003

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.6

61.4

100

156

Z2446

NOMESCO Finland

Social worker

2.9

60.9

301

1089

N02AX02

ATC

tramadol; systemic, rectal

1.8

60.5

1527

10571

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.3

60.5

247

800

A02BC02

ATC

pantoprazole; systemic

1.9

60.5

2328

18336

WW500

NOMESCO Finland

Blood transfusion

3.5

59.7

217

653

V03AE02

ATC

sevelamer; oral

13.5

59.7

Z3231

NOMESCO Finland

Registered nurse

1.9

59.6

1014

6195

L04AD02

ATC

tacrolimus; systemic

7.9

58.7

105

R53

ICD-10 Finland

Malaise and fatigue

1.9

58.6

983

5971

J01FF01

ATC

clindamycin; systemic

1.9

57.7

971

5898

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

57.5

744

4128

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

57.4

755

4214

A03

ICPC

Fever

2.1

56.5

618

3219

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

56.0

398

1728

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

56.0

1714

12462

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

55.9

407

1787

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

55.2

655

3517

XW000

NOMESCO Finland

Bone marrow biopsy

3.3

54.7

218

695

B34.9

ICD-10 Finland

Viral infection, unspecified

4.3

54.6

146

354

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

54.5

1247

8308

A07AA09

ATC

vancomycin; oral

5.7

54.2

103

187

A10AB05

ATC

insulin aspart; parenteral

2.5

52.6

356

1509

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

52.4

799

4676

1369X

ICD-9 Finland

Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases

+∞

51.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

50.6

644

3536

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

50.5

682

3824

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

9.8

50.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

49.6

614

3336

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

13.7

49.4

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

48.0

492

2488

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

47.3

1225

8371

V03AE01

ATC

polystyrene sulfonate; oral

5.2

47.2

193

UJF32

NOMESCO Finland

Coloscopy

1.8

47.1

931

5884

L03AA02

ATC

filgrastim; parenteral

3.8

47.1

147

399

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.9

47.1

234

847

H05BX01

ATC

cinacalcet; oral

8.8

47.0

B01AB05

ATC

enoxaparin; parenteral

1.8

46.3

1084

7190

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.7

45.7

259

1004

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.9

45.7

219

777

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

45.3

452

2259

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

45.2

238

888

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

44.3

214

762

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.8

43.5

141

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

43.4

866

5466

H02AB02

ATC

dexamethasone; systemic

2.2

43.3

423

2095

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

42.9

497

2624

JN4AD

NOMESCO Finland

Body CT examination

2.1

42.8

451

2299

N03AX16

ATC

[U] pregabalin

1.8

42.7

789

4864

Z50.1

ICD-10 Finland

Other physical therapy

2.8

42.5

231

876

Z3226

NOMESCO Finland

Physiotherapist

1.9

42.5

653

3799

ZXE00

NOMESCO Finland

One hour or less

1.7

42.5

1279

9037

A10AC01

ATC

insulin (human); parenteral

2.3

42.4

346

1590

Z49.0

ICD-10 Finland

Preparatory care for dialysis

6.2

41.7

116

B01AA03

ATC

warfarin; systemic

1.8

41.5

805

5031

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.8

41.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

41.2

285

1216

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.0

40.9

190

662

137

Kela drug reimbursment

Uraemia requiring dialysis

6.7

40.8

A10AE04

ATC

insulin glargine; parenteral

2.1

40.3

401

1997

C07AB07

ATC

bisoprolol; oral

1.6

40.2

1717

13189

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

40.1

331

1527

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

40.1

1136

7870

N02BE01

ATC

paracetamol; systemic, rectal

2.0

39.4

2906

25773

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

38.5

266

1134

R11

ICD-10 Finland

Nausea and vomiting

2.2

38.4

347

1661

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

38.3

568

3256

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

38.3

659

3960

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

38.3

1247

8927

A04AA01

ATC

ondansetron; systemic, rectal

2.3

38.2

308

1406

R4110

NOMESCO Finland

Physiotherapy

1.7

38.2

938

6241

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

37.9

330

1556

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

37.1

276

1216

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

8.0

37.1

H02AB07

ATC

prednisone; oral

1.9

37.0

497

2756

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.2

36.2

147

473

NHQ40

NOMESCO Finland

Amputation of toe

4.2

35.8

229

L28

ICPC

Limited function/disability (L)

1.8

35.7

727

4580

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

13.2

35.7

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.4

35.7

131

A07AA02

ATC

nystatin; oral

2.5

34.8

236

997

A04AA02

ATC

granisetron; systemic, transdermal

2.4

34.5

240

1025

WW200

NOMESCO Finland

Immunization

3.5

34.0

120

354

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

11.8

33.4

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

33.2

480

2720

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.3

33.1

204

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

33.0

253

1129

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

32.9

391

2073

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

5.9

32.7

102

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

32.7

440

2435

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

32.6

621

3827

A02BC01

ATC

omeprazole; systemic

1.6

32.5

914

6252

H02AB09

ATC

hydrocortisone; systemic

3.7

32.4

106

297

13608

ICD-8 Finland

Other and unspecified infective and parasitic diseases

+∞

32.3

A06AD11

ATC

lactulose; oral

1.8

32.3

593

3615

V03AE03

ATC

lanthanum carbonate; oral

9.8

32.1

Z2221

NOMESCO Finland

Medical doctor

1.6

31.8

876

5956

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

31.6

440

2460

A05AA02

ATC

ursodeoxycholic acid; oral

4.5

31.5

174

B03XA01

ATC

erythropoietin; parenteral

5.5

31.5

113

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

31.4

281

1337

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

8.0

31.1

A98.5

ICD-10 Finland

Haemorrhagic fever with renal syndrome

3.9

31.0

241

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

7.2

30.9

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

30.2

306

1528

N05CF01

ATC

zopiclone; oral

1.6

30.2

1082

7815

A28

ICPC

Limited function/disability NOS

1.7

30.1

698

4532

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.4

29.8

109

329

AA1AD

NOMESCO Finland

CT of head and brain

1.6

29.6

1016

7260

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

29.5

203

862

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

7.7

29.3

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.9

29.2

233

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

29.2

370

2003

ZX108

NOMESCO Finland

Inhalation

6.4

29.1

TGC00

NOMESCO Finland

Bronchial lavation

3.2

28.7

114

362

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

5.9

28.7

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

28.5

163

634

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.9

28.4

S97

ICPC

Chronic ulcer skin

2.2

28.4

262

1262

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.8

28.3

234

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

28.2

371

2033

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

28.2

385

2136

H02AB04

ATC

methylprednisolone; systemic

1.8

27.9

471

2791

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.7

27.5

151

575

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

27.5

343

1845

SPAT1255

SPAT

Intravenous administration of medicine

2.2

27.4

258

1251

P01AB01

ATC

metronidazole; oral, rectal

1.5

27.4

1183

8858

N19

ICD-10 Finland

Unspecified kidney failure

2.5

27.3

175

719

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

27.2

203

895

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

10.4

27.1

WVA20

NOMESCO Finland

Medicine administration

3.0

27.1

123

423

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.7

26.8

M10.9

ICD-10 Finland

Gout, unspecified

2.1

26.7

284

1443

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.4

26.6

Z49.2

ICD-10 Finland

Other dialysis

5.9

26.6

N06AX11

ATC

mirtazapine; oral

1.5

26.4

1062

7820

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

26.3

918

6549

3AC01, ,

NOMESCO Finland

5.0

26.3

113

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

26.2

107

346

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

26.1

272

1371

I50.0

ICD-10 Finland

Congestive heart failure

1.9

26.1

334

1811

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

26.1

472

2852

A10AE05

ATC

insulin detemir; parenteral

2.3

26.0

207

938

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

26.0

853

6001

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.7

25.9

137

512

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

25.6

602

3903

B05DB

ATC

Hypertonic solutions

6.0

25.6

N05AH04

ATC

quetiapine; oral

1.7

25.6

550

3485

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.1

25.3

107

353

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

25.3

240

1167

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

25.3

278

1429

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

25.2

151

601

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.3

25.1

303

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

25.1

143

555

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

25.1

1120

8409

UKC02

NOMESCO Finland

Cystoscopy

1.7

24.9

589

3823

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.8

24.9

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.5

24.8

135

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.2

24.8

311

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

24.8

923

6667

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

24.6

153

620

ZY010

NOMESCO Finland

Hospital outpatient

2.4

24.4

171

732

J02AC01

ATC

fluconazole; systemic

1.5

24.4

1064

7940

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

24.3

393

2294

J01CA04

ATC

amoxicillin; systemic

1.5

24.3

2512

22198

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

24.3

171

734

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.2

24.3

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

24.3

716

4903

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.5

24.1

246

SPAT1254

SPAT

Administration of medicine

1.7

24.0

516

3263

L03AA13

ATC

pegfilgrastim; parenteral

2.5

24.0

152

621

Z51.5

ICD-10 Finland

Palliative care

1.9

23.8

337

1888

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

23.7

255

1300

P01BA02

ATC

hydroxychloroquine; oral

2.0

23.7

255

1301

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

23.6

1330

10422

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.7

23.4

208

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.2

23.1

288

TK810

NOMESCO Finland

Hemofiltration

6.4

23.1

R06.0

ICD-10 Finland

Dyspnoea

1.5

23.0

902

6567

B05DA

ATC

Isotonic solutions

5.3

23.0

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.3

23.0

WX002

NOMESCO Finland

Sedation and analgesia

1.6

22.9

607

4045

A10AD05

ATC

insulin aspart; parenteral

3.1

22.9

305

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

22.8

167

729

N05BA04

ATC

oxazepam; oral

1.5

22.2

825

5933

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

22.1

106

376

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

22.1

177

804

K65.0

ICD-10 Finland

Acute peritonitis

4.1

21.8

149

PAW37

NOMESCO Finland

Biopsy of temporal artery

5.4

21.8

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.5

21.7

120

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

21.7

806

5790

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

21.7

192

909

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

21.5

297

1648

H26.3

ICD-10 Finland

Drug-induced cataract

6.3

21.4

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

21.4

758

5390

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.7

21.2

106

ZX112

NOMESCO Finland

Subcutaneous

3.1

21.0

284

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

21.0

400

2444

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

21.0

241

1257

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.3

20.9

128

205

Kela drug reimbursment

Chronic hypertension

1.5

20.8

937

6989

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.8

20.8

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

6.1

20.8

N17.8

ICD-10 Finland

Other acute renal failure

3.8

20.7

173

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.4

20.7

140

591

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.8

20.6

107

396

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

20.5

179

842

J01XX08

ATC

linezolid; systemic

5.2

20.5

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

20.5

329

1914

N05BA01

ATC

diazepam; systemic, rectal

1.7

20.4

409

2533

L04AX03

ATC

methotrexate; systemic

1.9

20.4

292

1639

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.9

20.4

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

20.3

359

2146

J01EA01

ATC

trimethoprim; systemic

1.5

20.3

791

5726

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.4

20.3

139

590

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.1

20.3

285

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

20.2

161

729

L88

ICPC

Rheumatoid/seropositive arthritis

2.4

20.2

137

579

J01AA02

ATC

doxycycline; systemic

1.5

20.1

2391

21202

WX892

NOMESCO Finland

Monitored bed care

1.9

20.1

265

1448

K83.0

ICD-10 Finland

Cholangitis

3.4

20.1

215

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.6

20.1

A02BC05

ATC

esomeprazole; systemic

1.4

20.1

1197

9401

N06AB04

ATC

citalopram; systemic

1.6

20.1

623

4296

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

20.0

165

758

RD210, ,

NOMESCO Finland

3.5

20.0

201

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

19.9

155

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

19.8

252

1361

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

19.8

257

1398

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

19.8

113

440

L04AA13

ATC

[U] leflunomide

3.1

19.7

279

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

19.7

181

869

E000001, ,

ATC

1.6

19.7

586

4000

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

19.7

206

1039

C03DA01

ATC

spironolactone; oral

1.7

19.6

429

2719

SPAT1263

SPAT

Sampling

1.4

19.5

1241

9848

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

19.4

536

3594

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

6.2

19.4

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.3

19.3

148

660

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5.1

19.3

Z94.4

ICD-10 Finland

Liver transplant status

8.4

19.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.4

19.1

138

599

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.1

19.1

268

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

19.1

198

995

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

19.1

161

747

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

19.1

306

QDA10

NOMESCO Finland

Incision of skin of lower limb

5.0

19.0

RS221, ,

NOMESCO Finland

3.7

18.9

161

R81

ICPC

Pneumonia

2.3

18.9

138

603

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

18.8

147

661

R31

ICD-10 Finland

Unspecified haematuria

1.7

18.8

376

2325

J05AB11

ATC

valaciclovir; oral

1.6

18.7

431

2764

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

4.8

18.7

RS220, ,

NOMESCO Finland

3.8

18.7

153

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.6

18.7

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

18.6

236

1274

R41.0

ICD-10 Finland

Disorientation, unspecified

2.4

18.6

133

576

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.9

18.5

136

K92.1

ICD-10 Finland

Melaena

2.0

18.3

204

1052

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

18.3

654

4640

J01FA06

ATC

roxithromycin; oral

1.4

18.3

1169

9256

Z99.2

ICD-10 Finland

Dependence on renal dialysis

25.2

18.2

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.5

18.1

175

A12BA01

ATC

potassium chloride; oral

2.1

18.1

183

911

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.3

18.1

108

ZZA00

NOMESCO Finland

Split skin graft

2.5

18.0

110

443

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.3

18.0

A04

ICPC

Weakness/tiredness general

1.6

17.9

520

3524

J01CF02

ATC

cloxacillin; systemic

2.8

17.9

317

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.3

17.8

109

SPAT1262

SPAT

Handing over of treatment supplies

1.5

17.8

548

3762

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

17.8

279

1610

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

17.7

231

1257

C08CA01

ATC

amlodipine; oral

1.4

17.6

1231

9876

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.3

17.6

139

628

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.4

17.6

102

N30.0

ICD-10 Finland

Acute cystitis

1.6

17.5

520

3541

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

17.5

195

1007

ZXA00

NOMESCO Finland

Right side

1.4

17.4

810

6045

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.9

17.4

294

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

7.4

17.4

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.4

17.3

I50.1

ICD-10 Finland

Left ventricular failure

2.0

17.2

198

1033

L01BA01

ATC

methotrexate; systemic

2.4

17.2

119

508

Z51.88

ICD-10 Finland

Other specified medical care

2.9

17.1

292

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

6.9

17.0

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

16.9

390

WX730

NOMESCO Finland

Conventional respirator

3.3

16.9

193

R55

ICD-10 Finland

Syncope and collapse

1.6

16.9

375

2380

C08CA02

ATC

felodipine; oral

1.7

16.9

330

2027

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

16.8

803

6016

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.2

16.8

143

666

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

16.7

807

6060

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

16.7

208

1116

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.6

16.7

156

C07AB02

ATC

metoprolol; systemic

1.5

16.6

683

4971

A49

ICD-10 Finland

Bacterial infection of unspecified site

6.5

16.6

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

15.1

16.6

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

16.6

313

R07.3

ICD-10 Finland

Other chest pain

1.7

16.6

330

2035

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

16.6

119

516

H3603, E103,

ICD-10 Finland

4.5

16.6

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

16.5

167

832

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

16.4

239

1347

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

3.6

16.4

148

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

16.3

161

795

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

12.2

16.3

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

16.3

1332

10922

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.0

16.3

234

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

16.2

119

521

M46.4

ICD-10 Finland

Discitis, unspecified

5.8

16.2

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

16.1

302

1834

E86

ICD-10 Finland

Volume depletion

2.4

16.1

108

455

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

16.0

277

1645

TAB00

NOMESCO Finland

Lumbar puncture

2.2

15.9

135

629

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

15.9

126

571

E0000UV, ,

ATC

1.4

15.8

1215

9851

A12AA12

ATC

[U] calcium acetate

14.5

15.8

R51.80

ICD-10 Finland

Headache

1.6

15.8

435

2907

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.3

15.8

123

553

N05CF02

ATC

zolpidem; oral

1.5

15.7

482

3300

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

15.7

196

1052

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

19.3

15.5

A10AB01

ATC

insulin (human); parenteral

2.3

15.5

116

513

R42

ICD-10 Finland

Dizziness and giddiness

1.4

15.5

720

5359

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

15.4

125

571

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

15.4

157

785

B01AB10

ATC

tinzaparin; parenteral

1.7

15.4

327

2052

A29

ICPC

General symptom/complaint other

1.6

15.4

430

2884

AN1

Coronary angiography

1.6

15.3

376

2444

Z94.1

ICD-10 Finland

Heart transplant status

12.4

15.3

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

15.2

739

5544

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

15.1

216

1210

C02AC05

ATC

moxonidine; oral

2.0

15.1

158

797

J96.0

ICD-10 Finland

Acute respiratory failure

3.1

15.1

197

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

15.0

109

475

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

14.9

120

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.2

14.9

122

560

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

14.9

791

6024

SPAT1229

SPAT

Assessment of need for aid

1.7

14.8

255

1510

R4190

NOMESCO Finland

Nutritional therapy

2.2

14.8

121

555

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.6

14.8

350

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.9

14.8

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

14.8

202

1117

NFQ20

NOMESCO Finland

Amputation of femur

3.8

14.8

121

N03AX12

ATC

[U] gabapentin; oral

1.5

14.7

466

3209

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

14.6

212

1194

N05CD07

ATC

temazepam; oral

1.6

14.6

390

2586

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

6.4

14.5

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.7

14.5

278

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

14.5

370

2427

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.3

14.5

166

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.3

14.5

166

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.6

14.5

132

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

14.5

127

600

T89

ICPC

Diabetes insulin dependent

2.2

14.4

126

594

M05BX04

ATC

denosumab; parenteral

1.9

14.4

197

1089

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

14.4

2063

18269

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.6

14.4

308

R33

ICD-10 Finland

Retention of urine

1.7

14.4

300

1873

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.7

14.3

297

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.7

14.3

286

J01MA06

ATC

norfloxacin; oral

1.6

14.3

385

2558

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.9

14.3

225

WX882

NOMESCO Finland

High dependency care

2.4

14.3

411

E87.5

ICD-10 Finland

Hyperkalaemia

2.6

14.3

321

N06AX16

ATC

venlafaxine; oral

1.6

14.2

370

2439

SPAT1301

SPAT

No procedures

1.4

14.2

922

7253

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.3

14.1

102

444

ZXA05

NOMESCO Finland

Left side

1.4

14.1

733

5551

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.2

14.1

179

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

14.1

371

2451

M86.6

ICD-10 Finland

Other chronic osteomyelitis

6.4

14.1

R02

ICPC

Shortness of breath/dyspnoea

1.5

14.1

419

2846

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

14.0

250

1497

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.2

13.9

165

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

13.9

331

M10.3

ICD-10 Finland

Gout due to impairment of renal function

5.2

13.9

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.6

13.8

5BA08, ,

NOMESCO Finland

4.9

13.8

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.4

13.7

147

C01DA14

ATC

isosorbide mononitrate; oral

1.5

13.7

573

4172

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

13.7

112

515

NGQ20

NOMESCO Finland

Amputation of lower leg

4.3

13.6

N03AX09

ATC

lamotrigine; oral

2.1

13.6

132

649

WZC30

NOMESCO Finland

Teaching

1.5

13.5

481

3393

R52.0

ICD-10 Finland

Acute pain

2.3

13.5

106

479

M05BA04

ATC

alendronic acid; oral

1.7

13.5

271

1675

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.6

13.5

295

C01AA05

ATC

digoxin; systemic

1.6

13.5

310

1983

L01AA01

ATC

cyclophosphamide; systemic

5.2

13.4

N05AH03

ATC

olanzapine; systemic

1.9

13.4

182

1004

212

Kela drug reimbursment

Gout

2.5

13.4

337

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

13.4

176

961

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

13.4

214

1242

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

13.4

368

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.0

13.3

152

792

A01AB09

ATC

miconazole; local oral

1.7

13.3

254

1549

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

3.4

13.3

140

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

13.3

559

4072

K81.0

ICD-10 Finland

Acute cholecystitis

2.5

13.3

321

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

13.3

372

2493

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

13.2

132

655

C07AG02

ATC

carvedilol; oral

1.8

13.2

197

1119

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

13.1

255

1562

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

13.1

209

1211

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.6

13.1

117

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.7

13.1

253

WX610

NOMESCO Finland

Patient controlled analgesia

4.5

13.1

R50.8

ICD-10 Finland

Other specified fever

4.6

13.0

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

4.1

13.0

RS222, ,

NOMESCO Finland

3.3

13.0

142

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.9

13.0

199

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

13.0

199

WX213

NOMESCO Finland

Lower leg blockade

3.8

13.0

104

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

6.1

12.9

J01CA08

ATC

pivmecillinam; oral

1.3

12.9

1062

8639

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.1

12.9

128

635

H04AA01

ATC

glucagon; nasal, parenteral

2.7

12.8

250

K92.0

ICD-10 Finland

Haematemesis

2.3

12.8

394

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.1

12.8

174

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

12.8

509

3668

R60.0

ICD-10 Finland

Localized oedema

1.5

12.7

397

2721

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

12.7

476

3388

N06AA09

ATC

amitriptyline; systemic

1.6

12.7

276

1740

J04AB02

ATC

rifampicin; systemic

3.1

12.7

170

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

12.6

158

849

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

12.6

422

D11

ICPC

Diarrhoea

1.6

12.6

325

2137

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

12.5

157

844

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

12.5

193

1107

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.8

12.5

214

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.1

12.5

171

B01AB04

ATC

dalteparin; parenteral

1.9

12.5

159

860

WX402

NOMESCO Finland

General anaesthesia

1.4

12.5

599

4465

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.5

12.4

313

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

12.4

168

926

C10AC01

ATC

colestyramine; oral

2.4

12.4

368

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

12.4

130

657

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.1

12.4

124

616

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

12.4

866

6864

K85

ICD-10 Finland

Acute pancreatitis

2.8

12.4

210

A10BA02

ATC

metformin; oral

1.4

12.4

878

6976

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.0

12.3

178

L03AA14

ATC

lipegfilgrastim; parenteral

2.9

12.3

205

R03BB04

ATC

tiotropium bromide; inhalant

1.6

12.3

333

2213

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

12.3

195

1129

E000006, ,

ATC

1.8

12.3

188

1077

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.8

12.3

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.6

12.3

113

K83.1

ICD-10 Finland

Obstruction of bile duct

2.9

12.2

190

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.0

12.2

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.3

12.2

133

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.5

12.1

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.1

12.1

154

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.4

12.0

129

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.8

12.0

D07AA02

ATC

hydrocortisone; topical

1.5

11.9

380

2615

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.0

11.9

127

646

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

11.9

458

NF3AA

NOMESCO Finland

Femur X-ray examination

2.4

11.9

344

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.7

11.9

219

1322

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.8

11.9

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.2

11.8

100

466

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.4

11.8

333

TPX15

NOMESCO Finland

Removal of vascular injection port

5.4

11.8

A10BH05

ATC

linagliptin; oral

1.8

11.8

177

1008

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.4

11.8

352

R06AE07

ATC

cetirizine; oral

1.3

11.8

1181

9846

R52.2

ICD-10 Finland

Other chronic pain

2.1

11.8

115

567

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

14.7

11.8

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

11.7

226

1381

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

11.7

701

5416

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.2

11.6

142

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.8

11.6

201

K50.8

ICD-10 Finland

Other Crohn disease

3.1

11.5

153

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

3.9

11.5

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

3.9

11.5

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

11.5

275

1775

K56.7

ICD-10 Finland

Ileus, unspecified

2.6

11.5

259

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.7

11.5

C08CA05

ATC

nifedipine; systemic

1.7

11.5

198

1175

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

11.4

453

A10AB04

ATC

insulin lispro; parenteral

2.2

11.4

447

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.7

11.4

214

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.7

11.4

SPAT1138

SPAT

Guidance concerning bowel function

2.8

11.4

203

N06AB10

ATC

escitalopram; oral

1.4

11.4

514

3786

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

11.4

160

894

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

11.3

543

4042

J05AB01

ATC

aciclovir; systemic

1.4

11.2

602

4565

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

11.2

276

1793

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

11.2

591

4468

A01

ICPC

Pain general/multiple sites

1.6

11.2

300

1987

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.6

11.2

239

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

11.2

383

2675

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.9

11.2

183

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

5.6

11.2

H05BX02

ATC

paricalcitol; systemic

20.1

11.1

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.8

11.1

189

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

11.1

241

1519

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

11.1

212

1293

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

11.0

1065

8819

WW200, ,

SPAT

0.7

11.0

493

6557

X57

ICD-10 Finland

Unspecified privation

2.4

11.0

320

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.8

10.9

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.0

10.9

158

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

10.9

167

957

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.7

10.9

214

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

10.8

166

953

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

8.3

10.8

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.6

10.7

XF602

NOMESCO Finland

Bloodpressure monitoring

3.1

10.7

139

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

4.7

10.7

QDG10

NOMESCO Finland

Excision and repair of bedsore of lower limb

21.5

10.7

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.8

10.7

150

838

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.5

10.7

275

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

3.9

10.6

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.9

10.6

126

666

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

10.6

211

1300

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

10.6

265

1728

R52.9

ICD-10 Finland

Pain, unspecified

1.6

10.6

287

1906

UJF92

NOMESCO Finland

Capsular endoscopy

2.5

10.6

276

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.2

10.6

402

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.3

10.5

115

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

10.5

1109

9273

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.3

10.5

364

N05AX08

ATC

risperidone; systemic

1.6

10.5

276

1821

R10.0

ICD-10 Finland

Acute abdomen

2.1

10.5

469

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

10.5

113

578

Z72.2

ICD-10 Finland

Drug use

4.8

10.5

E66.8

ICD-10 Finland

Other obesity

1.8

10.4

141

778

A10BB12

ATC

glimepiride; oral

1.6

10.4

234

1489

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

10.4

496

3686

C83.1

ICD-10 Finland

Mantle cell lymphoma

5.1

10.3

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.4

10.3

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

3.3

10.3

117

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

10.2

225

1423

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

4.7

10.2

SPAT1260

SPAT

Consultation of another employee

1.4

10.2

477

3531

C90.0

ICD-10 Finland

Multiple myeloma

2.9

10.2

165

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.4

10.1

103

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.7

10.1

199

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

10.1

161

934

J01DA01

ATC

[U] cefalexin

1.3

10.1

1800

16037

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.1

10.0

134

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

10.0

424

N03AF02

ATC

oxcarbazepine; oral

2.1

10.0

471

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

4.5

10.0

WNF00

NOMESCO Finland

Infection source and contact determination

4.6

10.0

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.1

10.0

R4180

NOMESCO Finland

Podiatric therapy

2.8

10.0

167

S06.0

ICD-10 Finland

Concussion

1.5

9.9

309

2115

W19

ICD-10 Finland

Unspecified fall

1.5

9.9

296

2010

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.3

9.9

304

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.9

9.9

157

N05AD01

ATC

haloperidol; systemic

2.0

9.8

103

522

R50.1

ICD-10 Finland

Persistent fever

12.2

9.8

I20.00

ICD-10 Finland

Unstable angina

2.0

9.8

105

536

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

4.3

9.8

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

4.3

9.8

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.9

9.8

114

599

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

9.8

217

1375

N05AA02

ATC

levomepromazine; systemic

1.9

9.8

117

621

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

9.8

171

1019

D07AC01

ATC

betamethasone; topical

1.3

9.8

1022

8519

HAC20

NOMESCO Finland

Total mastectomy

2.0

9.8

100

503

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.6

9.7

203

I20.09

ICD-10 Finland

Unstable angina

1.7

9.7

190

1166

SPAT1172

SPAT

Guidance concerning hydration

2.2

9.7

370

X58

ICD-10 Finland

Exposure to other specified factors

1.4

9.7

394

2842

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.9

9.7

153

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1.8

9.7

136

760

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

13.4

9.7

E000003, ,

ATC

1.9

9.7

118

631

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.1

9.6

127

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.5

9.6

246

K56.0

ICD-10 Finland

Paralytic ileus

3.1

9.6

122

RJ410, ,

NOMESCO Finland

5.0

9.6

A07EA06

ATC

budesonide; oral, local oral

2.0

9.6

100

507

SPAT1336

SPAT

Request for examination

1.9

9.5

114

605

C03AA03

ATC

hydrochlorothiazide; oral

1.5

9.5

275

1852

SPAT1342

SPAT

Referral to specialised care

2.8

9.5

171

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

9.5

534

6877

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

9.5

290

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.5

9.5

247

N06AX21

ATC

duloxetine; oral

1.5

9.5

306

2109

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.5

1019

8516

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

9.5

578

4464

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.3

9.5

303

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

3.5

9.5

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

9.5

248

1635

N02BF02

ATC

pregabalin; oral

1.7

9.5

181

1105

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

9.4

739

5922

K02.9

ICD-10 Finland

Dental caries, unspecified

2.6

9.4

201

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

3.9

9.4

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.9

9.4

110

580

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.4

9.4

261

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.4

9.4

255

130

Kela drug reimbursment

Malignant tumour

1.5

9.3

267

1796

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.2

9.3

114

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

4.9

9.3

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.7

9.3

185

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.3

750

6035

B37.7

ICD-10 Finland

Candidal sepsis

10.7

9.3

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

9.3

492

C09AA05

ATC

ramipril; oral

1.3

9.3

762

6146

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

9.2

234

1532

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.5

9.2

J01DC02

ATC

cefuroxime; systemic

1.8

9.2

134

759

3025

Kela drug reimbursment

Calcium carbonate

3.9

9.1

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.4

9.1

246

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.7

9.1

165

993

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.8

9.1

153

M54.5

ICD-10 Finland

Low back pain

1.3

9.1

989

8269

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.8

9.1

138

790

A41.4

ICD-10 Finland

Sepsis due to anaerobes

5.0

9.1

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

4.0

9.0

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.7

9.0

182

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

9.0

303

2108

S70.0

ICD-10 Finland

Contusion of hip

1.8

9.0

130

734

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

9.0

498

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2.5

9.0

218

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.5

9.0

218

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

8.9

111

597

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.8

8.9

K70.1

ICD-10 Finland

Alcoholic hepatitis

4.2

8.9

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

8.9

344

R13

ICD-10 Finland

Dysphagia

1.6

8.9

209

1344

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.2

8.9

107

B37.08

ICD-10 Finland

Other candidal stomatitis

3.3

8.9

R18

ICD-10 Finland

Ascites

2.3

8.9

268

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.7

8.9

178

K86.3

ICD-10 Finland

Pseudocyst of pancreas

4.3

8.9

M35.1

ICD-10 Finland

Other overlap syndromes

4.3

8.9

TNG10

NOMESCO Finland

Puncture of knee

3.0

8.8

123

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.3

8.8

281

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.5

8.8

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

8.6

8.8

J01FA09

ATC

clarithromycin; systemic

1.3

8.8

781

6361

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

8.8

301

G72.8

ICD-10 Finland

Other specified myopathies

2.4

8.7

251

PE1AT

NOMESCO Finland

Femoral artery PTA

2.7

8.7

174

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

14.1

8.7

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

8.7

121

676

U71

ICPC

Cystitis/urinary infection other

1.6

8.7

178

1108

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

8.6

519

JAH00

NOMESCO Finland

Laparotomy

2.0

8.6

429

J01CF05

ATC

flucloxacillin; systemic

1.6

8.6

199

1276

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

8.6

125

708

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

8.2

8.6

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

11.6

8.6

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

8.6

274

1887

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

8.5

298

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.7

8.5

170

C09AA02

ATC

enalapril; systemic

1.3

8.5

595

4684

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

8.5

346

2496

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.1

8.5

351

Angiography of the heart and coronary arteries

1.6

8.5

209

1360

WF004

NOMESCO Finland

Palliative radiotherapy

2.2

8.5

325

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

8.5

126

718

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

8.5

221

1457

G04CA02

ATC

tamsulosin; oral

1.3

8.5

779

6369

TK820

NOMESCO Finland

Peritoneal dialysis

4.2

8.4

78880

ICD-8 Finland

Other general symptoms, Pyrexia of unknown origin

4.2

8.4

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.2

8.4

319

B01AC04

ATC

clopidogrel; oral

1.4

8.4

508

3912

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

8.4

1868

16895

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.6

8.4

177

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.0

8.4

116

J01DA09

ATC

[U] cefadroxil

1.3

8.4

700

5646

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

3.9

8.4

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

8.4

136

794

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

8.4

1157

9930

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

8.4

517

M81.4

ICD-10 Finland

Drug-induced osteoporosis

4.3

8.4

JAH01

NOMESCO Finland

Laparoscopy

1.8

8.4

111

610

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.1

8.4

366

C02CA01

ATC

prazosin; oral

2.3

8.4

275

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.8

8.4

124

706

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

8.4

301

2122

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.6

8.4

172

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

6.7

8.3

AB1

AVR mechanical

4.7

8.3

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

8.3

387

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

8.3

227

1511

L01BC06

ATC

capecitabine; oral

1.9

8.3

106

576

A07EC02

ATC

mesalazine; oral, rectal

1.7

8.3

138

812

JJC00

NOMESCO Finland

Allogenic transplantation of liver

8.5

8.3

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

8.5

8.3

105

Kela drug reimbursment

Adrenal cortical hypofunction

10.8

8.3

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.8

8.2

145

C09CA06

ATC

candesartan; oral

1.3

8.2

644

5153

E87.6

ICD-10 Finland

Hypokalaemia

1.9

8.2

107

586

A10AA01, ,

ATC

2.1

8.2

350

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.4

8.1

216

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.9

8.1

WX872

NOMESCO Finland

Intensive care

1.7

8.1

146

878

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.5

8.1

UJD02

NOMESCO Finland

Gastroscopy

1.7

8.1

137

811

B96.5

ICD-10 Finland

Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters

17.2

8.1

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

11.7

8.1

A04AD12

ATC

aprepitant; systemic

2.4

8.1

211

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.3

8.1

WW300

NOMESCO Finland

Transfer of autologic stem cells

6.8

8.1

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

8.1

202

1320

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

8.0

399

2979

B02.9

ICD-10 Finland

Zoster without complication

1.6

8.0

192

1241

I50

ICD-10 Finland

Heart failure

1.8

8.0

107

590

Z94.2

ICD-10 Finland

Lung transplant status

10.0

8.0

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

22.1

8.0

Z75.5

ICD-10 Finland

Holiday relief care

2.8

8.0

136

M01CB01

ATC

sodium aurothiomalate; parenteral

2.7

8.0

153

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

8.0

157

967

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.5

8.0

200

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.1

8.0

104

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.5

8.0

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.3

8.0

237

Catheterization and pressure measurement of the left side of the heart

2.2

7.9

275

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

7.9

111

621

E83.50

ICD-10 Finland

Hypercalcemia

2.6

7.9

165

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

3.4

7.9

G82.2

ICD-10 Finland

Paraplegia, unspecified

4.3

7.9

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.3

7.9

250

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.2

7.9

308

ZXA10

NOMESCO Finland

Bilateral

1.3

7.9

505

3922

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

7.9

368

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

2.9

7.9

126

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

7.9

168

1056

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

7.9

493

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

7.9

321

2316

A49.0

ICD-10 Finland

Staphylococcal infection, unspecified site

4.6

7.9

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

13.0

7.9

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

7.8

7.9

D01

ICPC

Abdominal pain/cramps general

1.4

7.8

315

2267

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

6.1

7.8

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.1

7.8

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

3.5

7.8

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

7.8

102

559

S29

ICPC

Skin symptom/complaint other

1.3

7.8

549

4323

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

8.5

7.8

E16.19

ICD-10 Finland

Other specified hypoglycaemia

4.1

7.8

A02BC03

ATC

lansoprazole; oral

1.3

7.8

793

6556

J01XX05

ATC

methenamine; oral

2.9

7.8

127

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

2.9

7.8

127

L01BB05

ATC

fludarabine; systemic

10.8

7.8

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.0

7.8

418

M79.6

ICD-10 Finland

Pain in limb

1.2

7.8

1191

10321

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

9.4

7.8

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

7.8

275

1933

R4120

NOMESCO Finland

Occupational therapy

1.6

7.7

180

1156

L17

ICPC

Foot/toe symptom/complaint

1.3

7.7

828

6887

K08.3

ICD-10 Finland

Retained dental root

1.5

7.7

215

1438

SPAT1211

SPAT

Application of soft bandage

1.5

7.7

236

1610

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.2

7.7

298

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

15.0

7.7

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.6

7.7

156

Z01.7

ICD-10 Finland

Laboratory examination

1.4

7.7

434

3306

-44

ICPC

Preventive immunization/medic

1.5

7.7

220

1480

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.1

7.7

101

N05AX12

ATC

aripiprazole; systemic

1.9

7.7

490

U14

ICPC

Kidney symptom/complaint

2.3

7.7

241

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

7.7

264

1845

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.5

7.7

174

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

7.7

107

599

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

3.4

7.6

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.1

7.6

319

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.6

443

3390

J94.8

ICD-10 Finland

Other specified pleural conditions

2.3

7.6

242

A02BA02

ATC

ranitidine; systemic

1.3

7.6

542

4275

C10AA01

ATC

simvastatin; oral

1.2

7.6

1249

10900

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

1.9

7.6

457

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

7.6

175

1122

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.3

7.6

255

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

11.9

7.6

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

11.9

7.6

R03AC02

ATC

salbutamol; inhalant

1.2

7.6

1523

13572

A10AA02, ,

ATC

1.8

7.6

102

565

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

2.8

7.5

135

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

3.5

7.5

J01XE01

ATC

nitrofurantoin; oral

2.3

7.5

243

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.4

7.5

218

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.2

7.5

R05

ICPC

Cough

1.3

7.5

657

5325

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.1

7.5

328

I25.2

ICD-10 Finland

Old myocardial infarction

1.5

7.5

228

1554

D64.8

ICD-10 Finland

Other specified anaemias

2.2

7.5

282

H3600, E103,

ICD-10 Finland

3.0

7.5

108

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.5

7.5

176

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

7.1

7.5

A87.9

ICD-10 Finland

Viral meningitis, unspecified

3.7

7.5

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.0

7.5

356

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

7.4

363

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.2

7.4

283

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

7.4

159

1001

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

7.4

489

R06.4

ICD-10 Finland

Hyperventilation

2.5

7.4

171

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

7.4

109

620

J01FA10

ATC

azithromycin; systemic

1.2

7.4

1471

13080

N05AF03

ATC

chlorprothixene; systemic

2.1

7.4

310

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

3.4

7.4

M10.0

ICD-10 Finland

Idiopathic gout

1.8

7.4

112

643

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

13.4

7.4

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

13.4

7.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.4

777

6446

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

7.4

165

1051

HA1AA

NOMESCO Finland

X-ray mammography

1.6

7.3

178

1155

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

7.3

142

872

N03AX14

ATC

levetiracetam; systemic

2.0

7.3

400

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.0

7.3

407

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

7.3

146

904

-2, ,

ICPC

3.6

7.3

M03BX01

ATC

baclofen; systemic

2.2

7.3

253

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.2

7.3

266

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

7.3

241

1672

RJ421, ,

NOMESCO Finland

4.1

7.3

T90

ICPC

Diabetes non-insulin dependent

1.3

7.3

688

5632

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

7.3

161

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.4

7.2

191

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

7.2

1012

8667

G41.9

ICD-10 Finland

Status epilepticus, unspecified

3.8

7.2

WX199

NOMESCO Finland

Other local analgesia

1.8

7.2

551

J01MA01

ATC

ofloxacin; systemic

1.5

7.2

234

1616

SAA04

NOMESCO Finland

Special examination of mouth

1.7

7.2

128

768

306

Kela drug reimbursment

Erythropoietin and darbepoetin

4.3

7.2

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

2.4

7.2

210

J01FA01

ATC

erythromycin; systemic

1.4

7.2

320

2344

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.0

7.2

409

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

2.6

7.2

156

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

3.7

7.2

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.1

7.2

314

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.9

7.2

187

Kela drug reimbursment

MPA

30.1

7.1

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.1

7.1

328

RJ411, ,

NOMESCO Finland

3.6

7.1

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.9

7.1

425

G40.10

ICD-10 Finland

Simple partial seizures

3.4

7.1

D69.0

ICD-10 Finland

Allergic purpura

3.4

7.1

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.6

7.1

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

6.6

7.1

J43.9

ICD-10 Finland

Emphysema, unspecified

2.3

7.1

237

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

7.1

155

982

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

7.1

454

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.3

7.1

212

A48.8

ICD-10 Finland

Other specified bacterial diseases

6.0

7.1

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.3

7.0

206

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

8.8

7.0

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.0

639

5202

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

7.0

209

1419

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

3.6

7.0

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.9

7.0

413

D09

ICPC

Nausea

1.7

7.0

113

661

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.8

7.0

118

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.3

7.0

213

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

7.0

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.8

7.0

514

R4130

NOMESCO Finland

Speech therapy

1.9

7.0

414

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.2

7.0

P19

ICPC

Drug abuse

3.4

7.0

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.1

7.0

291

N05AA01

ATC

chlorpromazine; systemic, rectal

2.6

6.9

147

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

5.5

6.9

K65.9

ICD-10 Finland

Peritonitis, unspecified

5.8

6.9

A10BB01

ATC

glibenclamide; oral

1.6

6.9

143

894

UJK02

NOMESCO Finland

ERCP

1.9

6.9

430

C02EA02, ,

ATC

1.6

6.9

137

848

H65.0

ICD-10 Finland

Acute serous otitis media

2.4

6.9

196

N03AB02

ATC

phenytoin; systemic

2.6

6.9

142

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

6.9

255

1809

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

6.9

292

2123

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.1

6.9

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.9

6.8

452

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.2

6.8

260

115

Kela drug reimbursment

Breast cancer

1.5

6.8

184

1223

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.5

6.8

172

H3600, E113,

ICD-10 Finland

2.5

6.8

166

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

6.8

147

928

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

6.7

6.8

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

3.8

6.8

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

6.8

125

758

XF404

NOMESCO Finland

Ambulatory ECG

1.5

6.8

237

1662

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.9

6.8

425

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.4

6.8

191

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

9.3

6.8

6BA02, ,

NOMESCO Finland

6.1

6.8

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

6.1

6.8

K75.0

ICD-10 Finland

Abscess of liver

6.1

6.8

C83.00

ICD-10 Finland

Lymphocytic lymphoma

5.6

6.7

N86

ICPC

Multiple sclerosis

3.6

6.7

B07.9

ICD-10 Finland

Verruca simplex

1.8

6.7

505

PB1AE

NOMESCO Finland

Ultrasound examination of arteries of upper extremity

16.7

6.7

N04BC05

ATC

pramipexole; oral

1.5

6.7

201

1366

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

2.9

6.7

104

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

6.7

479

3775

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

6.7

249

1766

D06

ICPC

Abdominal pain localized other

1.5

6.7

220

1524

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

3.5

6.7

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

3.1

6.7

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

6.7

427

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.7

6.7

121

ZY000

NOMESCO Finland

Hospital inpatient

2.6

6.7

144

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

6.7

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

2.2

6.7

243

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

2.9

6.7

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.0

6.7

364

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.0

6.7

371

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

6.7

239

1684

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

2.8

6.7

110

R03BA05

ATC

fluticasone; inhalant

1.3

6.6

465

3655

N03AE01

ATC

clonazepam; systemic

1.6

6.6

142

895

A10AB06

ATC

insulin glulisine; parenteral

2.8

6.6

116

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

3.7

6.6

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.7

6.6

Z00.8

ICD-10 Finland

Other general examinations

1.5

6.6

203

1387

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

6.6

147

935

N06AB06

ATC

sertraline; oral

1.4

6.6

271

1958

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

7.8

6.6

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.4

6.6

175

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

5.5

6.6

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

2.9

6.6

100

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

2.8

6.6

111

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

6.6

119

719

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

6.6

502

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1.8

6.6

473

XX9XE

NOMESCO Finland

Other ultrasound examination

3.2

6.6

E87.2

ICD-10 Finland

Acidosis

3.5

6.6

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

6.5

488

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

8.7

6.5

XQ902

NOMESCO Finland

Other photography

2.6

6.5

140

192

Kela drug reimbursment

Fulvestrant

3.8

6.5

A08

ICPC

Swelling

1.6

6.5

163

1066

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.8

6.5

106

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

6.5

106

622

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.5

6.5

158

A27

ICPC

Fear of other disease NOS

1.6

6.5

141

892

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.7

6.5

123

Z71.8

ICD-10 Finland

Other specified counselling

1.2

6.5

887

7562

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.8

6.5

100

578

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.9

6.5

439

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.2

6.5

240

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

6.5

233

1644

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.9

6.5

425

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

5.3

6.5

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

5.3

6.5

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.9

6.4

383

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

6.4

369

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

2.5

6.4

147

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.1

6.4

267

M54.8

ICD-10 Finland

Other dorsalgia

1.7

6.4

113

678

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

2.8

6.4

107

N03AX18

ATC

lacosamide; systemic

3.4

6.4

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.3

6.4

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

7.4

6.4

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.7

6.4

107

633

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

3.7

6.4

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

6.4

145

929

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

4.1

6.3

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

4.1

6.3

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

6.3

370

2832

ZX110

NOMESCO Finland

Intracutaneous

6.5

6.3

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

6.5

6.3

A21.9

ICD-10 Finland

Tularaemia, unspecified

8.2

6.3

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.1

6.3

A86

ICD-10 Finland

Unspecified viral encephalitis

3.6

6.3

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

6.3

297

2198

WX722

NOMESCO Finland

PEEP

1.6

6.3

125

774

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

6.0

6.3

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

11.0

6.3

7151

FHL

Kidney transplantation

11.0

6.3

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

6.3

589

4808

H3601, E103,

ICD-10 Finland

3.2

6.3

L04AX04

ATC

lenalidomide; oral

3.2

6.3

5AB14, ,

NOMESCO Finland

9.3

6.3

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

3.5

6.3

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

3.3

6.3

K81.9

ICD-10 Finland

Cholecystitis, unspecified

2.5

6.3

149

L04AA10

ATC

[U] sirolimus

18.0

6.3

Q61.1

ICD-10 Finland

Polycystic kidney, autosomal recessive

18.0

6.3

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

6.3

255

1841

C50.99

ICD-10 Finland

Breast, unspecified

2.0

6.3

352

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.8

6.3

103

AK1

HTX (heart transplant)

+∞

6.3

F03

ICD-10 Finland

Unspecified dementia

1.6

6.2

150

973

SPAT1236

SPAT

Informing family of child’s disability

2.1

6.2

257

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

6.2

202

1397

EBA00

NOMESCO Finland

Extraction of tooth

1.2

6.2

952

8208

JKA20

NOMESCO Finland

Cholecystectomy

1.8

6.2

460

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

2.9

6.2

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.4

6.2

162

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

6.2

324

2441

N03AG01

ATC

valproic acid; systemic, rectal

1.6

6.2

150

976

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

6.2

219

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

3.5

6.2

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.5

6.2

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

6.1

130

818

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

6.1

1174

10343

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

5.3

6.1

XX9XW, ,

NOMESCO Finland

3.2

6.1

EB1WA, ,

NOMESCO Finland

3.3

6.1

D06AX01

ATC

fusidic acid; topical

1.4

6.1

234

1670

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.9

6.1

369

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

2.5

6.1

151

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

2.8

6.1

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.8

6.1

PD1CD

NOMESCO Finland

Very extensive CT of abdominal aorta and branches

4.1

6.1

J86.9

ICD-10 Finland

Pyothorax without fistula

2.7

6.1

116

M05BA07

ATC

risedronic acid; oral

1.8

6.1

456

J20

ICD-10 Finland

Acute bronchitis

1.4

6.1

252

1826

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

6.0

213

1498

S76

ICPC

Skin infection other

1.6

6.0

149

973

U70

ICPC

Pyelonephritis/pyelitis

2.3

6.0

189

D638, N189,

ICD-10 Finland

10.0

6.0

R03AC13

ATC

formoterol; inhalant

1.6

6.0

133

846

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

6.0

224

1591

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.8

6.0

509

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

1777

8696

3.25

240.84

8.9

4.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1173

5341

2.85

166.92

3.1

1.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

293

586

5.39

139.93

8.0

5.5

1154.83

646.19

iu/ml

0.40

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

879

3767

2.81

136.34

2.6

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

915

4009

2.77

135.96

2.6

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

622

2222

3.21

133.49

2.3

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

330

773

4.63

130.56

2.3

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

449

1330

3.75

129.17

2.6

1.9

2.22

2.20

ug/l

0.01

413

1161

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

244

470

5.52

121.18

3.8

3.0

365.16

1878.58

u/ml

1.07

(3002032) Base excess in Venous blood by calculation

746

3162

2.75

116.13

8.0

3.6

1.56

1.75

mmol/l

0.79

655

2725

(3012544) pH of Venous blood

752

3273

2.68

110.55

7.8

3.7

7.37

7.38

1.23

540

1900

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

310

786

4.25

110.31

2.5

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

248

526

5.02

110.27

2.6

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

746

3255

2.67

108.96

8.0

3.6

5.75

5.83

kpa

1.20

733

3170

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

208

393

5.58

105.31

1.8

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

1417

8382

2.21

102.76

5.5

3.4

0.41

0.44

e6/l

0.23

1184

6250

(3002582) Erythrocytes [#/volume] in Urine

1576

9766

2.17

101.09

5.8

3.5

62.60

77.75

e6/l

0.37

1343

7550

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

783

3645

2.50

98.93

6.4

4.1

248.15

247.33

u/l

0.04

756

3445

(3026782) Osmolality of Urine

1094

5902

2.27

98.70

5.0

3.0

517.42

535.49

mosm/kgh2o

2.06

1017

5193

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

197

377

5.49

98.29

1.9

1.6

—

(3022096) Basophils/Leukocytes in Blood

1954

13252

2.16

98.10

11.9

6.5

0.61

0.66

4.98

1880

12392

(42870588) Differential panel, method unspecified - Blood

1557

9682

2.15

98.07

11.0

6.2

—

(3019069) Monocytes/Leukocytes in Blood

1957

13282

2.16

98.04

12.0

6.5

8.93

8.97

0.23

1884

12441

(3006504) Eosinophils/Leukocytes in Blood

1952

13262

2.15

97.17

11.9

6.4

2.66

2.83

2.47

1878

12408

(3003458) Phosphate [Moles/volume] in Serum or Plasma

835

4070

2.41

94.88

14.7

5.9

1.10

1.04

mmol/l

6.92

803

3781

(3002030) Lymphocytes/Leukocytes in Blood

1969

13558

2.11

92.83

12.0

6.4

24.70

26.97

14.54

1908

12849

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

330

991

3.59

91.91

1.6

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

1192

6846

2.16

90.43

4.7

2.8

5.05

5.24

e6/l

0.25

1122

6250

(3020779) Urea [Moles/volume] in Serum or Plasma

649

2882

2.56

89.77

17.3

7.0

11.64

10.51

mmol/l

3.16

629

2756

(3042936) Bacteria identified in Isolate by Culture

839

4206

2.33

88.62

2.9

2.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

881

4528

2.29

87.61

5.2

2.7

21.07

22.35

1.80

841

4199

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2109

15097

2.09

87.06

12.6

6.5

11.46

12.15

umol/l

0.99

2052

14389

(3004789) Transferrin [Mass/volume] in Serum or Plasma

926

4893

2.24

85.86

5.1

2.6

2.16

2.28

g/l

9.17

877

4506

(3018095) Leukocytes [#/volume] in Urine

1666

10986

2.04

85.84

6.7

4.1

86.07

107.09

e6/l

0.35

1361

7874

(3006315) Basophils [#/volume] in Blood

2030

14380

2.06

85.56

11.3

6.2

0.04

e9/l

2.25

1839

12295

(3001604) Monocytes [#/volume] in Blood

2025

14341

2.06

85.29

11.2

6.2

0.62

0.60

e9/l

3.25

1829

12264

(3018010) Neutrophils/Leukocytes in Blood

1916

13307

2.04

85.12

11.5

6.3

60.11

57.92

11.96

1868

12703

(3019198) Lymphocytes [#/volume] in Blood

2049

14680

2.04

82.19

11.5

6.3

1.80

1.89

e9/l

0.73

1878

12882

(3012095) Magnesium [Moles/volume] in Serum or Plasma

927

4976

2.20

82.11

6.0

3.3

0.79

0.82

mmol/l

7.96

880

4694

(3024354) Oxygen [Partial pressure] in Venous blood

609

2737

2.50

81.45

6.6

3.1

4.89

4.49

kpa

3.32

599

2662

(3022948) Iron [Moles/volume] in Serum or Plasma

959

5241

2.17

80.99

5.1

2.6

11.11

12.64

umol/l

7.94

911

4865

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

430

1633

2.88

80.41

1.8

1.5

—

(3013115) Eosinophils [#/volume] in Blood

2057

14829

2.02

80.17

11.8

6.4

0.19

e9/l

1.38

1867

12873

(3013650) Neutrophils [#/volume] in Blood by Automated count

2182

16098

2.04

79.22

18.7

9.2

4.52

4.22

e9/l

6.67

2001

13928

(3032080) INR in Blood by Coagulation assay

1955

13878

2.00

79.21

25.7

17.4

1.32

inr

0.03

1718

11669

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

215

529

4.28

79.13

2.0

1.4

—

(36304419) Bacteria [Presence] in Urine

1291

7981

2.01

77.50

5.4

3.3

0.09

60.71

estimate

0.49

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

214

533

4.22

77.49

1.9

1.4

—

15.78

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

200

473

4.44

77.47

1.9

1.4

156.25

148.83

au/ml

0.33

134

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

229

622

3.88

73.57

1.7

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

229

622

3.88

73.57

1.7

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

499

2152

2.55

72.23

4.1

2.9

10.23

10.74

g/l

1.64

468

1982

(3000991) Gas panel - Venous blood

589

2756

2.38

71.31

13.0

8.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1831

13081

1.89

68.57

9.9

5.1

33.61

35.27

g/l

24.94

1737

12243

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

130

239

5.62

67.57

1.9

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1385

9094

1.90

66.96

4.1

2.6

56.57

68.58

u/l

0.72

1327

8407

(3009445) Proteinase 3 Ab [Units/volume] in Serum

332

1215

2.93

65.95

1.8

1.4

12.35

17.65

iu/ml

0.24

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1990

14718

1.88

65.61

16.3

7.4

1.21

mmol/l

0.97

1753

12669

(3027273) Bicarbonate [Moles/volume] in Venous blood

371

1449

2.76

65.22

7.2

3.3

24.97

25.16

mmol/l

0.48

365

1398

(3004119) Hemoglobin [Mass/volume] in Venous blood

458

1985

2.52

65.22

6.6

3.1

123.54

128.33

g/l

4.32

450

1929

(3028026) IgM [Mass/volume] in Serum or Plasma

410

1701

2.61

63.88

2.2

1.9

1.19

1.40

g/l

1.50

371

1563

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

188

495

3.97

62.98

1.5

1.3

298.06

255.68

u/ml

0.93

131

295

(3004809) Band form neutrophils/Leukocytes in Blood

192

514

3.90

62.84

5.2

3.6

1.48

1.66

0.25

172

452

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1387

9246

1.86

62.82

5.0

3.2

32.89

35.91

u/l

0.75

1325

8729

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

854

4845

2.03

62.80

4.4

3.2

2.28

2.25

e6/l

0.03

499

2431

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

902

5235

1.99

62.09

4.3

3.1

1.14

1.15

e6/l

0.04

552

2828

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

198

547

3.79

61.96

1.7

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

582

2864

2.25

61.90

10.3

7.5

1.37

mmol/l

0.00

574

2810

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

219

652

3.53

61.30

1.7

1.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

698

3784

2.07

57.53

3.8

2.6

1.85

1.78

0.88

656

3360

(3048929) Epstein Barr virus Ab [Presence] in Serum

240

791

3.19

57.03

1.6

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2184

17005

1.83

57.02

10.7

5.2

6.97

6.79

mmol/l

3.04

2118

16159

(3018677) aPTT in Platelet poor plasma by Coagulation assay

812

4677

1.97

56.33

2.9

2.2

30.24

29.81

1.14

795

4543

(3010375) cycloSPORINE [Mass/volume] in Blood

107

7.54

55.16

30.3

30.5

98.37

119.99

ug/l

1.97

(3026250) Tacrolimus [Mass/volume] in Blood

113

7.32

55.11

51.5

40.5

7.28

7.07

ug/l

0.38

102

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

280

1028

2.88

55.03

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

362

1527

2.54

54.12

2.0

1.7

1.77

1.51

g/l

4.65

316

1311

(3007853) Bacteria identified in Skin by Aerobe culture

647

3499

2.06

53.26

2.6

1.8

—

(3018418) pH of Serum or Plasma

1300

8827

1.78

52.85

10.0

4.1

7.40

0.25

1035

6390

(3023520) Reticulocytes [#/volume] in Blood

564

2918

2.12

52.16

4.3

2.6

68.97

68.66

e9/l

0.07

418

2157

(1616796) Gas panel - Central venous blood

212

685

3.24

52.00

5.4

4.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

166

459

3.75

51.81

1.7

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

432

2025

2.30

50.95

11.1

8.6

24.43

24.81

mmol/l

1.15

426

2014

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

472

2310

2.22

50.13

7.9

3.9

139.81

92.64

ng/l

5.57

410

1986

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

185

563

3.42

49.95

1.7

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

223

774

3.02

48.38

2.2

1.6

0.24

g/l

0.22

210

739

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

273

1066

2.70

47.57

4.3

3.4

0.31

0.35

iu/ml

0.84

152

584

(3017181) Myelocytes/Leukocytes in Blood

512

2639

2.11

47.49

6.4

4.4

0.88

0.90

0.05

257

835

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

530

2769

2.09

47.42

3.9

2.5

37.87

56.76

u/l

0.53

464

2323

(3021589) Normoblasts [#/volume] in Blood

1658

12300

1.70

47.32

23.1

11.8

0.00

e9/l

0.85

1409

10039

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

226

804

2.94

46.91

2.2

1.6

1.19

g/l

0.08

214

766

(3015736) pH of Urine

1616

11959

1.69

46.11

5.5

3.6

6.34

6.25

2.60

976

6668

(3031040) Bacteria [#/volume] in Urine by Automated count

2294

18657

1.75

45.83

7.6

5.0

48.83

1771.28

e6/l

3.62

305

(46235355) HIV 1 and 2 tests - Meaningful Use set

771

4656

1.85

44.94

2.5

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

920

5865

1.79

44.84

5.7

4.0

269.83

587.22

ng/l

1.20

758

4756

(1761482) Bacteria [#/volume] in Urine by Culture

210

738

2.97

44.52

6.7

4.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

111

255

4.47

44.50

3.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

111

255

4.47

44.50

3.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

111

255

4.47

44.50

3.2

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

594

3314

1.97

43.98

4.6

2.8

9.44

8.56

umol/l

0.32

527

2930

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

179

5.20

43.89

1.8

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

507

2679

2.05

43.74

3.4

2.6

64.51

66.27

g/l

5.28

471

2461

(3024891) Influenza virus A+B Ag [Presence] in Specimen

208

735

2.95

43.66

1.4

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

122

306

4.10

43.62

3.1

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

552

3014

2.00

43.45

2.5

1.6

—

(3000330) Specific gravity of Urine by Test strip

338

1525

2.35

43.26

6.0

3.5

1.02

ratio

0.63

319

1388

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

197

4.94

43.13

1.7

1.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

478

2500

2.07

42.32

6.3

4.2

0.62

0.73

0.72

234

784

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

953

6241

1.74

41.78

2.3

1.7

1.47

1.34

mg/l

0.47

776

4846

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1183

8217

1.68

41.74

3.2

2.3

3.13

2.86

mg/l

3.08

1052

7087

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1290

9167

1.67

41.69

3.1

2.2

184.58

226.45

u/l

1.13

1256

8670

(3044640) Blood type and Crossmatch panel - Blood

1316

9403

1.66

41.62

4.1

2.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

174

5.05

40.18

1.8

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

187

652

2.98

40.17

3.0

2.7

35.75

35.82

umol/l

0.01

162

584

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

411

2072

2.12

39.99

5.7

4.1

5.07

5.16

kpa

1.25

399

1978

(3014051) Protein [Presence] in Urine by Test strip

1135

7866

1.67

39.98

4.8

3.0

0.19

0.05

1.29

218

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

223

857

2.72

39.97

2.3

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

265

1109

2.51

39.95

2.4

2.2

356.38

474.95

ug/l

0.62

250

1051

(3021440) Promyelocytes/Leukocytes in Blood

475

2528

2.03

39.94

6.5

4.4

0.08

0.11

0.64

227

726

(3026493) Urate [Moles/volume] in Serum or Plasma

1104

7599

1.68

39.91

4.5

2.8

361.16

350.96

umol/l

2.15

1003

6645

(3036481) Cortisol [Moles/volume] in Serum or Plasma

491

2645

2.01

39.90

2.4

2.2

366.74

381.20

nmol/l

0.57

463

2430

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

146

441

3.42

39.85

8.9

6.6

12.12

12.22

mg/l

0.10

138

412

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

112

282

4.08

39.84

3.3

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1714

13187

1.62

39.62

14.3

6.7

1.20

1.21

mmol/l

1.69

1645

12136

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

366

1770

2.20

39.57

5.4

4.0

1.91

1.85

mmol/l

0.10

258

1294

(3011412) CD3 cells [#/volume] in Blood

102

241

4.33

39.46

2.9

2.2

1111.23

1186.25

e6/l

0.35

213

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

514

2826

1.97

39.36

3.1

2.2

0.20

0.21

g/l

0.61

473

2625

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

144

5.45

39.28

3.9

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

144

5.45

39.28

3.9

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

144

5.45

39.28

3.9

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

144

5.45

39.28

3.9

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

632

3726

1.86

39.14

1.6

1.3

499.35

498.34

titre

0.00

155

805

(40760892) CBC W Ordered Manual Differential panel - Blood

933

6166

1.71

39.11

7.7

4.7

—

(44790048) Parainfluenza type 2 nucleic acid detection

133

385

3.56

38.75

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

133

385

3.56

38.75

1.7

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

133

385

3.56

38.75

1.7

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

133

385

3.56

38.75

1.7

1.5

—

(3025941) Bacteria identified in Stool by Culture

315

1444

2.31

38.73

1.5

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

183

650

2.92

38.02

1.6

1.5

—

(3009343) pH of Capillary blood

397

2015

2.10

37.85

5.8

4.2

7.41

1.01

352

1690

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

400

2041

2.09

37.60

2.3

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

252

1063

2.48

37.30

2.5

2.7

—

(3017354) Segmented neutrophils/Leukocytes in Blood

121

338

3.68

37.18

5.9

3.5

62.27

57.32

1.42

101

290

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

219

867

2.63

36.98

5.3

3.8

2.14

1.60

mg/l

7.90

200

774

(3033658) Prothrombin time (PT) actual/Normal

1055

7302

1.65

36.65

7.9

4.2

85.94

86.73

0.45

1033

7145

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.41

36.31

3.6

2.6

0.60

0.62

mmol/l

1.25

(3010421) pH of Blood

235

977

2.51

35.86

7.2

4.0

7.41

0.49

229

967

(3037467) Urinalysis macro (dipstick) panel - Urine

2290

19179

1.63

35.15

8.0

4.7

2.09

2.96

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

108

293

3.78

34.63

2.5

21.78

40.93

iu/ml

0.85

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

106

284

3.82

34.61

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

385

2014

2.03

33.65

1.9

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

522

3029

1.86

33.55

6.3

3.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

209

851

2.55

33.29

3.4

2.6

3.63

3.58

g/l

0.16

203

809

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

205

827

2.58

33.28

1.8

1.3

—

(3012501) Base excess in Blood by calculation

170

626

2.81

33.02

6.9

4.7

2.45

2.65

mmol/l

0.44

131

418

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

153

532

2.97

33.01

1.4

1.2

55.56

335.56

titre

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2484

21360

1.65

32.95

18.0

8.2

90.96

80.42

u/l

10.47

2419

20284

(3019977) pH of Arterial blood

599

3643

1.79

32.94

10.3

7.8

7.42

7.41

0.98

344

2023

(3013290) Carbon dioxide [Partial pressure] in Blood

170

627

2.80

32.93

6.9

4.7

4.96

5.04

kpa

0.60

163

617

(3027315) Oxygen [Partial pressure] in Blood

170

627

2.80

32.93

6.9

4.7

8.07

8.48

kpa

2.56

163

616

(3025159) Blasts/Leukocytes in Blood

453

2531

1.91

32.68

6.5

4.6

0.31

0.25

0.09

197

668

(3035350) Ketones [Presence] in Urine by Test strip

1864

15013

1.55

32.60

6.4

4.0

20.93

3.93

estimate

1.28

486

3245

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

637

3956

1.76

32.56

2.4

1.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1679

13224

1.55

32.42

5.1

3.1

179.23

131.57

ug/l

5.43

1591

12307

(3009261) Glucose [Presence] in Urine by Test strip

1871

15095

1.55

32.36

6.4

4.0

0.13

0.11

estimate

0.05

455

3032

(3030981) Hyaline casts [#/volume] in Urine by Automated count

451

2533

1.90

31.98

3.7

2.6

0.52

0.47

e6/l

0.18

441

2437

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

151

531

2.93

31.93

1.4

1.2

386.00

433.78

titre

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

448

2515

1.90

31.80

4.1

3.1

287.49

232.03

ng/l

1.40

411

2297

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1265

9386

1.56

31.75

4.7

3.3

2539.81

1698.26

ng/l

5.06

1130

8129

(3021601) Nitrite [Presence] in Urine by Test strip

1840

14833

1.54

31.61

6.4

4.0

0.00

estimate

0.31

474

3183

(3035947) Staphylolysin Ab [Units/volume] in Serum

131

5.12

31.55

1.3

1.1

3.00

5.17

iu/ml

—

(3003396) Base excess in Arterial blood by calculation

592

3630

1.77

31.53

10.3

7.7

0.71

0.94

mmol/l

0.60

480

2965

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

111

5.49

31.00

1.2

—

(40758558) Short blood count panel - Blood

1160

8483

1.57

30.81

12.7

6.2

—

(3042733) HLA Ab [Presence] in Serum

6.49

30.70

5.3

4.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

10.09

30.05

12.4

15.0

4.99

5.73

mmol/l

0.77

(3035933) Granulocytes/Leukocytes in Blood

159

596

2.75

29.86

4.6

3.3

58.66

58.54

0.03

159

596

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

195

810

2.50

29.76

1.8

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

240

1095

2.28

29.67

3.8

3.5

52.96

70.46

mg/l

0.50

186

936

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

587

3656

1.74

29.41

10.4

7.8

5.00

5.10

kpa

1.59

568

3504

(3027801) Oxygen [Partial pressure] in Arterial blood

587

3656

1.74

29.41

10.4

7.8

11.39

12.05

kpa

2.85

568

3508

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

258

1218

2.21

29.37

3.9

1.9

—

(40767503) Oxygen content in Capillary blood by calculation

164

630

2.69

29.37

4.1

2.6

15.51

16.19

2.04

164

621

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

457

2645

1.84

29.35

4.1

2.4

7.01

7.41

ug/l

0.18

415

2312

(3016502) Oxygen saturation in Arterial blood

537

3263

1.77

29.33

10.9

8.1

95.24

95.35

0.17

514

3150

(3019309) Folate [Moles/volume] in Red Blood Cells

798

5403

1.63

29.06

2.1

1.8

1176.72

1167.83

nmol/l

0.08

648

4099

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

268

1296

2.16

28.72

2.6

2.3

3.75

3.77

g/l

0.09

254

1185

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

268

1297

2.16

28.66

2.6

2.3

7.82

7.42

g/l

3.08

253

1185

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

268

1297

2.16

28.66

2.6

2.3

4.20

4.18

g/l

0.08

254

1186

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

220

983

2.33

28.55

3.7

3.3

2.08

4.12

ratio

1.18

119

586

(3034860) Kappa light chains.free [Mass/volume] in Serum

237

1095

2.25

28.42

3.9

3.5

57.90

54.54

mg/l

0.20

186

933

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

172

4.32

28.39

3.4

2.1

0.56

0.71

e9/l

1.11

165

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

266

3.61

28.38

1.3

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

201

867

2.40

28.25

2.7

2.6

93.58

91.63

0.52

196

843

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

161

626

2.65

28.15

1.7

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1650

13214

1.50

27.69

4.5

2.9

—

estimate

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

238

1114

2.22

27.65

3.0

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

1137

2.21

27.45

2.5

2.3

10.22

10.35

g/l

0.16

223

1016

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

191

4.05

27.16

1.4

1.3

77.06

83.30

—

(3052851) Hemolysis interference index of Serum or Plasma

189

810

2.41

26.94

4.0

3.4

2.14

1.72

index

0.34

419

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

158

625

2.60

26.69

1.7

1.5

143.42

717.35

e6/l

1.67

127

494

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

407

2337

1.85

26.67

9.1

3.8

1.22

mmol/l

0.51

383

2007

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

156

616

2.61

26.45

1.5

15.52

37.14

e6/l

0.78

118

460

(3035715) Granulocytes [#/volume] in Blood

133

486

2.81

26.22

4.2

3.3

4.34

e9/l

0.00

133

486

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

171

709

2.49

26.19

1.4

494.94

571.50

mg/l

1.33

162

674

(3006184) Hemoglobin [Mass/volume] in Capillary blood

174

728

2.47

26.14

3.0

2.3

125.42

128.64

g/l

0.88

146

576

(3016650) Hepatitis A virus Ab [Presence] in Serum

125

443

2.89

26.08

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

128

460

2.85

26.03

1.2

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

100

5.27

25.78

2.0

2.2

33.52

30.26

0.65

100

(3007164) IgA [Mass/volume] in Serum or Plasma

784

5419

1.59

25.74

1.9

1.5

2.47

2.53

g/l

0.28

552

3344

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

231

3.66

25.70

1.9

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

4.39

25.51

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

170

713

2.46

25.40

2.5

2.0

13.02

12.11

mg/l

0.54

159

656

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

151

602

2.58

25.11

1.5

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

181

3.99

24.90

2.0

2.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

155

631

2.53

24.68

1.3

3.97

3.78

mmol/l

0.94

148

590

(3002173) Hemoglobin [Mass/volume] in Arterial blood

487

3021

1.72

24.39

11.6

8.6

116.76

120.82

g/l

4.05

476

2948

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

7.36

24.17

2.1

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

108

4.88

23.64

4.9

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

108

4.88

23.64

4.9

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

198

3.75

23.49

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

269

1409

1.99

23.17

5.8

5.4

1.66

1.59

0.26

258

1330

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

110

4.79

23.14

5.0

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

486

3054

1.69

23.13

4.9

4.1

24.07

20.20

ug/l

0.19

404

2519

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1559

12624

1.44

23.07

3.4

2.4

77.12

77.57

nmol/l

0.25

1454

11318

(3036489) Thrombin time

217

1056

2.13

22.82

2.5

2.2

21.41

21.10

0.29

202

955

(3028271) Lactate [Moles/volume] in Capillary blood

125

478

2.68

22.61

2.9

1.9

1.50

1.71

mmol/l

2.21

125

467

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

292

3.18

22.60

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

250

1290

2.01

22.46

6.1

5.7

0.83

0.87

0.78

239

1215

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

117

4.59

22.41

2.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

117

4.59

22.41

2.6

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

187

865

2.23

22.33

1.7

1.5

0.41

8.86

iu/ml

0.55

154

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

170

3.88

22.03

3.3

2.2

549.36

536.65

e6/l

0.05

139

(40768446) Kidney Pathology biopsy report

4.91

22.01

2.1

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

963

7159

1.49

22.00

4.0

2.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1410

11282

1.43

21.85

6.8

4.1

45.68

64.35

ng/l

1.20

1103

8267

(3020876) Protein [Mass/time] in 24 hour Urine

103

363

2.90

21.75

3.4

2.3

1.45

1.35

g/24h

0.14

221

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

173

3.81

21.51

3.2

2.3

204.69

230.18

e6/l

0.42

150

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

178

3.76

21.43

2.3

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

143

4.11

21.31

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

175

3.77

21.16

2.3

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

137

570

2.46

20.85

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.63

20.85

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

167

759

2.26

20.81

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1267

10022

1.43

20.53

5.4

3.5

2.34

2.35

mmol/l

3.21

1195

9085

(3021960) Folate [Moles/volume] in Serum or Plasma

1120

8677

1.44

20.28

2.0

1.7

18.95

19.79

nmol/l

1.11

1016

7355

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

232

1210

1.99

20.20

2.8

2.3

3.28

2.95

g/l

4.30

217

1099

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

167

3.76

20.18

1.2

111.50

91.18

u/l

0.69

140

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

214

1088

2.03

20.01

3.3

369.10

4051.60

u/ml

0.84

180

939

(3024471) HLA-A [Type]

5.25

19.84

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

115

452

2.60

19.73

1.5

1.6

0.58

0.83

g/l

2.20

357

(3023420) DNA double strand Ab [Units/volume] in Serum

216

1108

2.02

19.71

2.8

1.7

9.86

6.87

iu/ml

0.57

254

(3024932) HLA-DR beta [Type]

5.25

19.37

1.2

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

169

796

2.18

19.31

3.3

2.5

221.72

189.80

3.69

164

760

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

223

1168

1.97

19.18

2.4

1.9

37.77

39.17

u/l

0.41

203

1022

(3016018) Differential panel - Cerebral spinal fluid

307

2.92

18.96

1.7

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

125

4.13

18.92

1.4

1.7

—

(3004451) EKG impression Narrative

175

3.59

18.87

1.5

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1573

13050

1.39

18.79

2.5

2.2

91.14

94.58

pmol/l

2.37

950

7046

(3008536) Aspergillus sp Ab [Presence] in Serum

5.72

18.51

4.0

1.5

—

(4035726) Immunohistochemistry procedure

381

2375

1.68

18.47

1.6

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1375

11179

1.39

18.42

6.6

4.0

0.31

0.27

estimate

0.05

413

2623

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

148

3.76

17.96

1.1

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1022

7922

1.42

17.96

6.0

3.5

0.10

0.16

estimate

0.20

378

2486

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

316

1893

1.74

17.70

12.8

9.5

24.02

24.24

mmol/l

0.49

309

1849

(3014148) Varicella zoster virus Ab [Titer] in Serum

308

2.84

17.69

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

342

2.74

17.64

2.2

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

338

2.74

17.48

2.2

1.4

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2287

20335

1.40

17.22

7.0

4.4

18.93

12.79

mm/h

40.61

2178

18979

(4062490) Immunoglobulin typing, IgG

269

2.95

17.18

1.6

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

313

2.79

17.17

7.0

3.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

270

2.93

17.07

1.5

1.3

2.88

2.97

g/l

0.15

201

(3015171) Extractable nuclear Ab [Units/volume] in Serum

195

1022

1.96

16.74

1.3

1.2

2.46

0.78

u/ml

0.55

(3024522) Salmonella sp identified in Specimen by Organism specific culture

341

2.69

16.65

2.2

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

209

1124

1.92

16.63

3.1

2.4

0.47

1.13

g/l

2.48

185

963

(3024139) IgG subclass 3 [Mass/volume] in Serum

270

2.90

16.48

1.5

1.3

0.44

0.42

g/l

0.14

199

(3027135) IgG subclass 1 [Mass/volume] in Serum

270

2.90

16.48

1.5

1.3

7.03

6.92

g/l

0.07

200

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

162

3.50

16.47

2.8

2.6

39.20

40.41

0.13

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

184

951

1.99

16.44

2.8

2.2

0.08

0.02

g/l

0.43

169

855

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

183

3.32

16.26

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2031

17793

1.37

16.17

5.1

3.3

70.27

50.40

u/l

9.12

1943

16646

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

291

2.79

16.01

3.3

2.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

142

3.63

15.89

3.3

3.5

0.75

1.15

1.38

142

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

230

3.00

15.53

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

230

3.00

15.53

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

154

762

2.07

15.53

1.4

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1832

15862

1.35

15.35

3.9

2.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

151

746

2.07

15.29

1.8

1.6

19745.97

14649.90

e6/l

0.42

111

517

(3042111) Morphology [Interpretation] in Bone marrow Narrative

118

531

2.27

15.12

2.1

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

218

3.02

15.08

1.2

129.09

128.86

titre

0.00

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

167

864

1.98

14.90

2.8

2.2

0.00

g/l

-0.00

160

812

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

353

2276

1.62

14.88

4.9

2.8

52.96

64.11

ml/min/173m2

4.52

180

984

(3014765) Yersinia sp identified in Stool by Organism specific culture

153

768

2.04

14.85

1.4

1.2

—

(3023410) Appearance of Cerebral spinal fluid

286

2.73

14.84

1.7

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

327

2.61

14.77

3.7

3.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

154

777

2.03

14.74

1.4

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

175

924

1.94

14.72

2.8

2.2

0.00

g/l

-0.00

160

813

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

211

3.02

14.66

1.3

2.08

2.15

mmol/l

0.14

198

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.21

14.58

1.3

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

168

879

1.96

14.51

1.4

1.5

270.79

279.27

ug/g

0.21

102

528

(3045142) Bone marrow Pathology biopsy report

343

2.55

14.40

1.6

1.3

—

(3000494) Fungus identified in Specimen by Culture

483

3375

1.50

14.22

2.0

1.4

—

(3047181) Lactate [Moles/volume] in Blood

172

914

1.93

14.20

5.7

6.4

1.37

1.32

mmol/l

0.33

144

796

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

155

795

2.00

14.18

1.5

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

482

3373

1.50

14.08

2.8

2.4

184.25

141.30

ug/g

1.27

411

2690

(3000012) Reticulocyte production index

108

483

2.28

14.06

3.6

2.2

0.82

0.89

0.69

339

(3007566) Smooth muscle Ab [Titer] in Serum

149

756

2.02

14.05

1.4

1.2

135.00

99.39

titre

0.24

(3011397) Hemoglobin [Presence] in Urine by Test strip

880

6888

1.38

13.90

5.6

3.9

0.29

0.12

0.33

(3006270) Folate [Moles/volume] in Blood

245

2.81

13.90

1.2

327.35

365.10

nmol/l

0.64

205

(3022493) Free Hemoglobin [Mass/volume] in Plasma

118

3.68

13.72

4.7

4.2

4219.91

69.80

mg/l

0.49

(3037756) Immunofixation for Serum or Plasma

139

694

2.05

13.71

2.1

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

169

918

1.89

13.08

2.0

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

281

1770

1.64

12.98

14.3

10.6

15.41

15.88

2.11

271

1703

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

142

733

1.98

12.78

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

327

2.48

12.77

2.4

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

327

2.48

12.77

2.4

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

377

2.37

12.68

5.0

2.5

—

(3004775) Volume in Urine collected for unspecified duration

224

2.80

12.64

2.6

2.3

757.86

629.63

1.32

147

(3023419) Bacteria identified in Sputum by Culture

403

2.32

12.61

2.7

2.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

329

2.47

12.61

2.4

1.4

—

(3042631) Mycobacterium sp identified in Specimen

399

2.32

12.45

2.8

2.7

—

(3022313) Gas panel - Capillary blood

235

1431

1.69

12.36

6.7

4.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

374

2.33

12.00

1.5

1.4

25453.14

71050.93

e6/l

1.20

214

(40758292) HTLV I+II Ab panel - Serum

4.84

11.89

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

762

5954

1.36

11.88

4.1

3.0

2.47

2.45

mmol/l

3.52

693

5343

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

226

2.73

11.88

1.4

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

296

1934

1.58

11.76

9.3

6.9

24.02

24.46

mmol/l

1.19

280

1848

(40761536) Microorganisms panel - Urine sediment

336

2261

1.54

11.72

7.4

4.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.36

11.68

1.6

1.7

—

(3011288) Drugs identified in Urine by Screen method Nominal

120

606

2.02

11.52

6.8

2.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

100

474

2.14

11.36

1.7

1.5

346.23

31.39

g/l

0.49

433

(3003181) Sodium [Moles/volume] in Urine

115

578

2.03

11.19

1.6

1.4

63.38

62.87

mmol/l

0.05

471

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

129

676

1.95

11.16

1.2

1.1

3.06

3.56

—

(3023199) Leukocytes [#/volume] in Pleural fluid

421

2.19

11.00

1.6

1.4

3868.61

3826.10

e6/l

0.01

293

(3000093) Morphology [Interpretation] in Blood Narrative

295

2.44

10.99

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.90

10.83

1.3

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

347

2.31

10.81

1.4

1.6

38.14

30.51

ng/l

0.38

347

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

170

2.91

10.80

1.7

1.5

5.88

6.26

u/l

0.06

139

(3012565) Volume of 24 hour Urine

123

3.28

10.80

2.8

2.7

1505.60

1938.16

1.35

109

(3013727) Leukocytes other/Leukocytes in Blood

3.61

10.62

4.1

3.9

50.87

52.92

0.20

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.36

10.50

1.4

1.1

1.17

1.18

mmol/l

0.36

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

131

3.16

10.42

1.7

2.3

54.52

110.03

umol/l

1.97

(3004446) Plasmodium sp identified in Blood by Light microscopy

8.19

10.30

2.5

2.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

241

2.52

10.01

1.8

1.4

15.27

13.57

u/l

0.81

229

(3016750) Collection duration of Urine

167

2.84

9.95

2.7

2.1

545.85

494.26

min

2.73

121

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.58

9.92

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

368

2.20

9.84

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

271

1817

1.54

9.60

2.5

2.4

25.45

19.44

au/ml

0.43

174

(3002523) Influenza virus A Ag [Presence] in Specimen

439

2.08

9.55

1.2

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

12.36

9.35

4.1

4.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

104

3.29

9.29

1.2

1.1

35.75

442.64

ng/l

0.99

(1001926) Buprenorphine [Presence] in Urine by Screen method

123

679

1.84

9.14

4.1

1.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

15.62

9.02

1.7

3.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

439

2.03

8.82

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

3.67

8.71

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

192

1218

1.61

8.66

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

130

2.95

8.65

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

402

2.07

8.62

1.3

1.2

1.86

3.85

u/ml

1.43

139

(21494890) Protein electrophoresis panel - 24 hour Urine

311

2.21

8.53

1.8

2.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.68

8.44

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

121

683

1.80

8.39

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

256

2.33

8.38

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.89

8.35

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.89

8.35

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.89

8.35

1.3

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

150

2.76

8.28

4.1

3.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

408

3050

1.39

8.15

2.0

1.8

1.62

1.51

1.87

355

2648

(3020393) Adenovirus Ag [Presence] in Stool

4.76

8.11

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

169

1058

1.63

8.06

5.4

3.3

1075.57

421.61

mg/l

0.42

102

456

(3016879) Cocaine [Presence] in Urine

135

797

1.72

8.04

4.1

2.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

333

2.13

7.99

1.5

1.6

73.54

63.40

1.65

208

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

112

630

1.80

7.88

1.3

1.2

1.00

4.46

u/ml

—

(3045788) Cell count panel - Pleural fluid

350

2.08

7.78

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.54

7.69

1.1

—

(40768806) Pleura Pathology biopsy report

345

2.08

7.68

1.7

1.6

—

(40768441) Liver Pathology biopsy report

198

2.45

7.65

2.2

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

129

2.81

7.58

8.9

6.9

36.57

55.56

u/ml

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

218

2.36

7.53

2.3

1.4

1.53

1.11

promille

1.13

169

(3003329) Lymphocytes/Leukocytes in Synovial fluid

256

2.25

7.51

1.8

1.4

23.67

26.29

0.22

151

(3020682) Albumin/Creatinine [Ratio] in Urine

1116

9633

1.24

7.49

5.4

4.2

19.70

10.97

mg/mmol

2.33

795

6150

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

241

1663

1.48

7.47

1.4

1.3

73.39

52.12

au/ml

0.46

113

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.35

7.37

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

312

2270

1.41

7.30

2.0

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.61

7.29

1.7

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

197

1315

1.53

7.16

1.2

1.1

66.32

1.59

u/ml

—

(40757373) Influenza virus identified in Isolate

3.56

7.14

1.3

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

235

1630

1.48

7.11

3.4

3.5

4.25

4.46

pmol/l

2.64

203

1439

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

322

2.07

7.10

1.4

1.3

337.68

351.54

u/l

0.08

309

(3019768) Coxiella burnetii Ab [Presence] in Serum

7.93

7.09

1.0

1.4

—

(3014271) Vancomycin [Susceptibility]

163

2.53

7.08

3.0

3.1

—

(3020891) Body temperature

215

1466

1.50

7.08

7.9

4.3

36.95

36.91

°c

0.90

209

1450

(3017732) Neutrophils [#/volume] in Blood

453

3518

1.33

7.06

3.8

3.3

4.98

4.77

e9/l

0.21

404

3017

(40768797) Stomach Pathology biopsy report

493

3877

1.32

7.03

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

127

768

1.68

6.97

1.3

1.2

33.25

3.39

u/ml

0.63

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

393

1.96

6.97

1.3

1.2

2.95

5.93

u/ml

1.28

179

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.40

6.96

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

104

595

1.77

6.96

3.6

2.0

0.96

0.85

nmol/l

0.72

495

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

159

2.53

6.92

1.6

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.83

6.90

1.4

2.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.45

6.83

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.69

6.80

1.1

—

(3013512) EKG study

1127

9814

1.22

6.80

5.7

3.8

—

0.74

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

132

813

1.65

6.76

1.4

1.2

25.28

37.63

u/ml

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

105

2.87

6.62

1.8

1.5

2.67

2.25

0.14

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2778

26536

1.29

6.62

44.7

17.4

32.42

25.68

mg/l

20.68

2609

22265

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

126

772

1.66

6.60

1.4

1.2

3.19

10.15

u/ml

1.54

118

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

539

4346

1.29

6.35

1.8

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

1135

9943

1.22

6.35

4.7

3.5

7.02

7.52

mmol/l

3.43

986

8387

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

167

1106

1.54

6.33

7.1

4.6

24.36

24.83

mmol/l

1.26

158

1013

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

245

3360

0.71

6.28

5.1

5.0

31.95

32.65

0.45

190

2212

(3027008) Opiates [Presence] in Urine

137

869

1.60

6.26

4.1

2.0

—

(3022621) pH of Urine by Test strip

309

2306

1.37

6.23

3.4

2.8

6.02

6.07

0.49

243

1607

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

742

6230

1.25

6.21

2.0

1.7

8948624.72

28701627.11

pmol/l

1.12

637

5174

(3000764) Benzodiazepines [Presence] in Urine

136

863

1.60

6.21

4.1

2.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

432

1.85

6.17

1.1

27.86

18.03

au/ml

—

100

(3028300) Cannabinoids [Presence] in Urine

137

873

1.59

6.15

4.1

1.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

127

2.61

6.13

1.1

1572.09

1513.58

miu/ml

0.10

127

(3022145) Colonoscopy Study observation

400

3117

1.32

6.07

1.5

1.4

—

(3027944) Amphetamines [Presence] in Urine

135

861

1.59

6.05

4.2

1.9

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.60

6.03

1.9

1.6

6.13

8.57

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

216

2.19

5.94

1.1

—

(4268621) Lupus anticoagulant assay

283

2.03

5.91

2.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

561

4586

1.27

5.90

1.3

9.72

11.79

u/ml

0.34

211

1759

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

595

4901

1.26

5.86

1.4

1.3

32.00

33.87

iu/ml

0.15

187

1484

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.87

5.77

1.1

—

(3002256) Pathology report gross observation

471

3779

1.29

5.75

1.4

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

356

1.90

5.74

1.6

1.4

6.15

6.45

mmol/l

0.37

335

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2501

26192

0.82

5.71

6.1

5.8

2.51

2.63

mmol/l

8.43

2350

24247

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

128

819

1.59

5.68

2.4

2.2

2423.09

6096.57

u/l

1.63

334

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

727

6149

1.23

5.63

1.4

1.3

1.94

1.58

u/ml

0.25

175

1664

(3017704) Immunofixation for Urine

189

2.24

5.60

2.0

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

190

2.23

5.53

2.0

1.4

111.83

85.28

umol/l

0.70

190

(3039162) Centromere protein B Ab [Units/volume] in Serum

326

1.92

5.49

1.3

39.94

64.16

u/ml

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

224

2.11

5.45

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

177

2504

0.69

5.42

1.7

2.0

3.59

3.48

ratio

0.47

137

1958

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

238

2.07

5.41

1.6

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

603

1.66

5.37

1.3

1.2

50.98

43.64

u/ml

—

(3044007) Cell count panel - Peritoneal fluid

2.79

5.30

3.3

2.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

567

1.68

5.29

1.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

9.11

5.28

5.0

4.5

—

(21494434) Karyotype in Bone marrow

291

1.94

5.16

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

123

1849

0.65

5.15

1.6

1.8

3.44

mmol/l

0.00

1304

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2441

25559

0.83

5.14

5.6

5.0

1.36

1.43

mmol/l

15.70

2296

23592

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

207

1495

1.41

5.11

2.6

2.4

—

(3016038) Potassium [Moles/volume] in Urine

197

2.15

5.09

1.7

1.2

36.60

36.50

mmol/l

0.01

179

(3008295) Osmolality of Serum or Plasma

335

1.87

5.09

1.2

1.4

278.38

278.29

mosm/kgh2o

0.01

247

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.76

5.08

1.1

93.80

97.03

0.18

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

251

2.01

5.08

1.1

—

(21494755) Public health laboratory ask at order entry panel

138

2019

0.67

5.06

1.4

—

(3017569) Oxygen content in Arterial blood

178

2.21

5.06

2.2

2.4

15.59

16.27

0.64

178

(3009466) Valproate [Moles/volume] in Serum or Plasma

417

1.77

5.01

6.1

5.3

350.12

349.68

umol/l

0.01

370

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

109

693

1.59

5.01

2.9

2.3

196.31

98.01

ug/min

1.09

427

(3044927) Protein electrophoresis panel - Urine

330

1.86

4.99

1.3

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

115

742

1.57

4.97

1.3

223.55

228.34

miu/ml

0.04

319

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2462

25734

0.83

4.93

5.7

5.1

4.36

4.52

mmol/l

11.66

2319

23927

(3050794) Legionella sp Ab [Presence] in Serum

5.43

4.91

1.1

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.67

4.91

3.2

2.1

8454.38

22060.47

e6/l

0.34

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

574

1.64

4.83

1.2

1.3

107.91

40.83

u/l

1.47

491

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

131

2.38

4.81

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

202

2.09

4.80

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

189

2.13

4.78

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

379

1.78

4.77

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

110

711

1.57

4.73

3.6

3.4

0.86

0.82

nmol/l

0.49

574

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

210

2.06

4.73

1.1

—

(3035880) pH of Pleural fluid

190

2.12

4.72

1.6

1.3

7.40

7.41

0.07

135

(4024509) Urine culture

186

1338

1.41

4.72

2.3

2.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

234

1751

1.36

4.69

1.6

1.3

332.32

235.38

u/ml

0.59

220

1629

(3023487) Leukocytes [#/volume] in Peritoneal fluid

109

2.49

4.62

3.7

2.4

562.95

849.83

e6/l

0.61

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

171

1217

1.43

4.61

4.1

3.3

74.47

69.21

u/ml

0.06

166

1174

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

192

2.10

4.61

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

100

637

1.59

4.59

5.6

3.4

84.64

825.79

u/ml

1.15

589

(44816559) Phosphatidylethanol [Mass/volume] in Blood

159

1118

1.44

4.58

1.7

0.29

0.32

mg/l

0.25

514

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

206

2.05

4.58

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

8.20

4.56

2.0

1.2

—

(4198724) Urine methamphetamine measurement

2.62

4.56

3.5

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.81

4.55

1.2

1.1

—

(3044889) 12 lead EKG panel

2017

18923

1.17

4.49

5.4

4.3

28203.40

2245.24

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

215

2.01

4.46

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

215

2.01

4.46

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

5.23

4.45

1.2

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

456

1.68

4.43

1.8

1.9

4.19

4.81

mmol/24h

0.76

395

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2300

21817

1.18

4.42

45.9

21.3

14.28

13.72

49.43

2279

21521

(3034274) Bile acid [Moles/volume] in Serum --fasting

302

1.84

4.34

2.4

2.1

7.70

7.80

umol/l

0.02

215

(3019150) Specific gravity of Urine by Refractometry

759

6598

1.19

4.33

6.2

4.3

1.02

1.24

kg/l

0.50

580

4439

(3002619) Bacteria identified in Specimen by Culture

2.89

4.33

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2303

21864

1.17

4.32

47.0

22.4

330.28

332.03

g/l

15.37

2285

21711

(3036071) Salmonella sp Ab [Titer] in Serum

2.66

4.32

1.0

—

(3042517) Benzodiazepines panel - Urine

5.52

4.28

1.1

1.6

—

(3013862) HLA-DP [Type]

8.91

4.28

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

408

1.71

4.25

1.5

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

349

1.76

4.22

1.7

1.3

—

(3012516) Albumin [Mass/volume] in Urine

1053

9432

1.17

4.19

4.6

3.5

96.89

48.06

mg/l

4.82

763

6209

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

250

1.89

4.11

1.4

1.3

21.10

13.66

u/l

0.74

232

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

8.02

4.06

1.3

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.34

4.04

1.1

—

(36660697) Celiac disease serology panel - Serum

272

2130

1.30

4.02

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.02

4.01

2.6

4.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.57

3.97

1.1

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.57

3.97

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.79

3.87

1.1

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

250

1.85

3.79

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

12.02

3.76

1.0

229.83

356.00

u/ml

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

281

1.79

3.71

1.5

1.3

180018.69

114889.86

e6/l

0.17

189

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.15

3.70

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

525

6122

0.83

3.69

3.0

3.3

0.80

0.82

ug/l

0.12

380

4114

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

985

10891

0.86

3.60

2.1

1.9

1.43

1.34

mmol/l

2.52

859

9181

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2445

25391

0.86

3.57

6.0

5.2

6.17

5.99

mmol/l

6.61

2268

23168

(46236302) HLA-C [Type] by High resolution typing

7.79

3.56

1.0

—

(40760410) HLA-B [Type] by High resolution

7.79

3.56

1.0

—

(3007463) Buprenorphine [Presence] in Urine

7.79

3.56

4.0

3.8

—

(40763590) HLA-DQ beta [Type]

7.79

3.56

1.0

—

(40760409) HLA-A [Type] by High resolution

7.79

3.56

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

221

1715

1.31

3.52

1.3

1.2

116.52

133.26

u/ml

0.29

634

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.24

3.50

1.2

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

158

2.04

3.50

1.2

75.97

84.71

u/l

0.42

144

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.33

3.50

1.1

1.2

860.00

1005.00

titre

—

(3023383) Lactate [Moles/volume] in Pleural fluid

2.33

3.50

1.6

1.4

3.58

3.29

mmol/l

0.14

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

10.01

3.49

1.0

0.24

0.19

g/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.88

3.48

1.6

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

934

8395

1.16

3.44

6.8

4.2

0.00

estimate

1.54

388

2881

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

785

0.58

3.41

1.1

0.71

0.64

ratio

—

(3024263) Appearance of Synovial fluid

153

2.04

3.40

1.9

1.7

—

(3049717) Cytology report of Urine Cyto stain

163

1218

1.36

3.38

2.5

2.7

—

(3051611) Lipemic interference index of Serum or Plasma

275

1.76

3.37

4.6

3.4

14.33

12.30

index

0.55

147

(3006653) Thiamine [Moles/volume] in Blood

147

2.05

3.36

1.2

133.67

137.50

nmol/l

0.16

147

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

147

2.05

3.36

19.2

19.1

1457.40

1435.80

nmol/l

0.06

142

(3034891) Synovial lining cells/cells in Synovial fluid

134

2.10

3.33

1.6

1.4

4.86

4.79

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

141

2.07

3.31

16.0

15.3

886.48

812.24

nmol/l

0.37

136

(3036670) Protein [Mass/volume] in Synovial fluid

2.34

3.24

1.0

1.3

34.85

39.32

g/l

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

123

2.12

3.19

2.8

1.7

28.13

27.90

umol/l

0.05

114

(3027923) C peptide [Moles/volume] in Serum or Plasma

171

1.94

3.18

1.7

1.4

1.25

1.22

nmol/l

0.05

123

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.74

3.15

1.3

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

131

2.07

3.12

2.3

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

118

2.13

3.10

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

337

2798

1.23

3.09

3.1

2.2

0.02

0.01

estimate

0.20

569

(3043410) Blood group antigens tested for on Red Blood Cells

2.33

3.07

4.5

1.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

5.01

3.05

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

2.51

3.04

2.2

2.0

0.16

0.25

e9/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.34

3.01

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.34

3.01

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

10.01

2.98

16.4

8.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

745

8310

0.87

2.98

4.0

4.7

23.59

22.06

1.76

393

4182

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.64

2.96

1.5

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2355

24421

0.88

2.93

5.0

4.3

1.39

1.28

mmol/l

8.36

2199

22329

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

850

0.63

2.93

1.1

1.47

1.53

g/l

0.85

850

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

221

1.77

2.89

3.1

1.9

—

(4281824) Cell count and differential, peritoneal fluid

266

1.70

2.88

1.4

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.71

2.87

1.2

1.0

92.80

91.26

titre

—

(3013762) Body weight Measured

6.68

2.86

1.0

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

2.81

1.1

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

307

1.64

2.79

1.1

1.3

1.65

1.47

nmol/l

0.43

275

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.17

2.76

1.1

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

8.34

2.75

1.0

—

(3016135) IgD [Mass/volume] in Serum

8.34

2.75

1.4

1.5

41.50

42.55

mg/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.51

2.70

1.7

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

264

1.68

2.69

2.2

2.0

1.17

1.50

u/field

0.34

145

(3024869) Neuronal Ab [Presence] in Serum

2.80

2.64

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.22

2.63

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.55

2.61

1.4

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

354

1.56

2.56

1.2

1.3

322.35

323.01

pmol/l

0.00

295

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

7.15

2.55

1.0

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

4.38

2.47

1.1

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.46

2.44

18.6

8.9

8.66

5.52

kpa

2.22

(3039000) Anion gap in Blood by calculation

622

1.41

2.44

8.6

7.8

11.84

11.26

mmol/l

0.86

552

(3047189) Immunofixation for 24 hour Urine

159

1.83

2.43

1.3

1.5

—

(40768443) Skin Pathology biopsy report

160

1256

1.29

2.43

1.4

1.2

—

(3018572) Chloride [Moles/volume] in Blood

623

1.41

2.42

8.6

7.8

104.53

105.24

mmol/l

0.68

553

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.18

2.40

1.1

1.2

17.54

8.58

pmol/l

—

(3034426) Prothrombin time (PT)

2.21

2.37

1.1

1.3

28.12

28.26

0.02

(3052592) Norovirus Ag [Presence] in Stool

2.42

2.36

1.9

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.51

2.35

1.6

1.2

0.70

2.14

mmol/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

111

1.99

2.35

1.1

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

331

1.55

2.32

1.3

—

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

348

1.53

2.30

1.3

0.17

0.24

nmol/l

0.72

281

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.95

2.28

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.10

2.22

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.34

2.21

1.6

2.8

767.57

574.15

ug/l

0.08

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.56

2.21

4.4

5.1

339.00

410.33

umol/l

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

5.56

2.21

2.2

3.0

2.08

4.40

mg/l

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

2.01

2.20

4.1

2.7

4.64

4.88

kpa

0.51

100

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

2.01

2.20

4.1

2.7

11.30

10.12

kpa

0.59

100

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.34

2.18

1.6

1.21

1.34

umol/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.29

2.15

33.5

10.6

104.83

104.86

g/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.69

2.15

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

181

1.72

2.15

1.0

1.1

14.93

17.81

u/ml

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.01

2.14

4.4

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

235

1.62

2.13

1.2

87.82

105.27

pmol/l

1.65

235

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

412

1.46

2.12

1.3

0.12

0.33

nmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

236

1.62

2.10

1.3

1.5

23.71

24.23

u/ml

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.21

2.09

1.1

1.2

—

(40768804) Tissue Pathology biopsy report

1170

10945

1.11

2.08

2.5

2.2

—

(3009677) Dengue virus Ab [Presence] in Serum

5.01

2.07

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

5.01

2.07

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.51

2.05

1.3

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.51

2.05

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.01

2.00

1.6

69.91

460.55

nmol/24h

0.67

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

163

1.72

1.98

1.6

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

163

1.72

1.98

1.6

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.97

1.93

1.3

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

195

1.65

1.93

1.4

2.1

8.93

8.04

mmol/l

0.60

195

(4195642) Thrombophilia screening test

355

1.47

1.92

1.1

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

380

1.45

1.92

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

212

1.61

1.88

1.3

1.1

—

65.06

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

732

1.32

1.87

1.4

11.84

9.06

u/l

1.06

590

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.65

1.86

1.3

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

107

1.87

1.86

1.2

1.3

141.40

169.10

mmol/24h

0.88

107

(3003694) ABO and Rh group [Type] in Blood

838

7748

1.11

1.84

1.6

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.53

1.83

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

115

1.83

1.82

1.2

3.66

4.86

umol/l

0.71

104

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.17

1.82

6.0

5.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

262

1.53

1.81

1.6

474.88

327.28

mu/l

0.75

212

(3019550) Sodium [Moles/volume] in Serum or Plasma

2767

27103

1.13

1.80

46.1

20.8

139.11

139.60

mmol/l

17.75

2715

26578

(3019225) pH of Specimen

322

2807

1.16

1.80

9.7

4.4

7.37

7.35

2.01

277

2009

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.05

1.80

1.3

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

713

1.31

1.76

2.3

2.0

3.34

12.08

iu/l

0.54

283

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.34

1.74

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.74

1.4

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.74

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.85

1.71

7.0

3.9

—

(37021550) Renin [Units/volume] in Plasma --upright

2.14

1.71

1.2

1.3

109.85

69.99

mu/l

0.26

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

315

1.47

1.71

1.3

27.76

24.78

u/l

0.22

256

(40768800) Prostate Pathology biopsy report

682

0.70

1.70

1.1

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2133

20648

1.09

1.68

4.9

4.3

14.71

14.85

pmol/l

1.66

1996

18847

(3023103) Potassium [Moles/volume] in Serum or Plasma

2769

27150

1.12

1.68

46.7

21.0

3.99

mmol/l

0.55

2714

26582

(44806420) Estimation of glomerular filtration rate

276

1.49

1.66

2.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

283

2461

1.16

1.65

1.6

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.25

1.63

1.2

1.0

—

(40765096) Chromosome analysis panel by Banding

105

1.81

1.62

1.3

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

213

1.55

1.62

1.5

1.3

2.88

1.32

u/ml

0.50

124

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

120

1.75

1.62

2.0

2.3

48.51

50.98

umol/l

0.12

102

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

288

1.46

1.57

1.1

1.2

104.36

95.64

1.09

273

(3013005) Retinol [Moles/volume] in Serum or Plasma

107

1.78

1.54

3.6

1.7

2.18

1.94

umol/l

0.58

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

441

1.37

1.54

1.1

48.11

1527.80

iu/ml

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.43

1.53

1.4

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

294

3338

0.87

1.52

15.4

7.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.34

1.52

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.60

1.51

10.6

4.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.83

1.51

1.5

1.3

6.84

135.45

ug/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

173

1456

1.20

1.50

2.1

2.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.86

1.50

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.44

1.47

1.6

1.2

201.82

117.91

ng/l

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.44

1.47

3.4

1.2

—

640.53

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.37

1.45

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

172

1.57

1.42

1.0

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

103

1.75

1.40

4.3

2.9

29.15

29.28

umol/l

0.02

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.08

1.38

1.4

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.94

1.38

2.2

3.5

—

97.71

au/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

150

1.60

1.37

1.1

1.0

1.04

1.17

u/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

198

1.52

1.37

1.0

810.21

699.22

ng/l

0.57

128

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

135

1.63

1.35

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

663

0.74

1.35

1.4

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

345

0.64

1.32

1.2

1.6

63.82

58.15

ug/l

0.30

345

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

152

1.58

1.31

1.3

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

416

0.67

1.31

1.6

1.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

176

1.54

1.31

3.0

1.9

182.72

122.86

ng/l

0.70

176

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.50

1.30

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

474

0.69

1.30

1.6

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.36

1.29

1.5

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.76

1.28

1.1

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2441

24920

0.92

1.27

8.3

6.6

41.22

39.70

mmol/mol

9.86

2305

23211

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

469

0.70

1.24

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

187

1.50

1.23

1.0

1.1

10.71

10.14

iu/ml

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

187

1.50

1.23

1.1

4.46

3.79

nmol/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

155

1.55

1.22

2.6

2.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.97

1.22

1.5

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.63

1.21

8.8

6.5

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

2.31

1.18

1.0

1.3

1.94

0.86

ml/s/173m2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.11

1.18

1.1

1.5

—

(3025130) Human papilloma virus identified in Specimen

350

1.35

1.17

2.5

1.9

—

(1761868) Lipid panel - Serum or Plasma

910

9600

0.93

1.15

3.7

3.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.34

1.12

1.0

1.1

0.02

u/ml

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.26

1.10

1.4

1.5

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.38

1.09

1.6

2.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.38

1.09

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.73

1.09

1.1

1.3

10.26

9.06

ug/l

0.32

(3017315) Amylase [Enzymatic activity/volume] in Urine

136

1.55

1.08

1.2

221.86

342.39

u/l

0.53

122

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

271

1.37

1.04

1.3

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

146

1.51

1.03

1.1

1.2

0.63

0.53

ratio

0.39

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

341

1.32

1.03

1.1

2.21

2.58

eliau/ml

0.19

140

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.89

1.01

1.2

1.3

89.00

69.76

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.88

1.00

2.1

3.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.00

1.00

1.1

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

134

1154

1.17

0.98

1.5

1.4

25.06

25.43

iu/l

0.05

121

986

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.95

0.97

1.4

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

137

1189

1.16

0.92

2.0

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

323

3522

0.91

1.6

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

159

1.45

0.91

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

340

1.30

0.90

1.4

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

153

1342

1.15

0.89

1.1

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.82

0.85

4.5

6.7

7.13

7.84

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.82

0.85

2.3

3.4

38.88

46.48

—

(3010813) Leukocytes [#/volume] in Blood

2829

28603

0.93

0.85

57.7

26.3

7.30

6.88

e9/l

9.53

2779

27919

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

279

2547

1.10

0.85

2.3

2.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

496

1.23

0.84

1.5

324.05

209.91

pmol/l

0.31

487

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

112

1.52

0.84

1.2

—

(3007461) Platelets [#/volume] in Blood

2828

28589

0.93

0.84

57.6

26.2

246.89

246.71

e9/l

0.04

2779

28003

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

179

1.40

0.84

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2829

28597

0.93

0.83

58.8

26.7

38.26

40.18

22.30

2792

28243

(3026361) Erythrocytes [#/volume] in Blood

2829

28597

0.93

0.83

57.5

26.2

4.27

4.45

e12/l

51.56

2775

27920

(3035941) MCH [Entitic mass]

2829

28596

0.93

0.83

57.3

26.1

30.20

30.37

5.08

2797

28255

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

256

2331

1.11

0.83

2.2

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1143

0.85

0.82

1.9

1.7

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2829

28594

0.93

0.82

57.4

26.1

91.40

91.32

0.35

2798

28254

(3000963) Hemoglobin [Mass/volume] in Blood

2830

28603

0.93

0.81

58.0

26.4

127.51

134.13

g/l

81.96

2797

28273

(44806071) Cardiolipin IgM antibody measurement

1.88

0.81

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

103

887

1.17

0.79

1.7

345.34

297.45

mu/l

0.55

806

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.82

0.79

3.7

2.6

0.47

0.70

ug/l

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.82

0.79

9.0

9.8

0.33

0.20

—

(4034850) Laboratory test

866

0.84

0.76

15.4

10.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

124

1.45

0.75

1.3

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

971

0.85

0.74

1.5

1.6

1007.87

1009.35

mu/l

0.01

802

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.08

0.74

1.6

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.67

0.74

1.0

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

231

2107

1.10

0.74

1.5

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.84

0.73

2.3

1.7

43.86

48.61

umol/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1000

10375

0.95

0.73

5.2

5.7

3.96

3.62

ug/l

0.15

901

9315

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

664

1.18

0.71

1.2

1.1

9.02

7.00

eliau/ml

0.19

(3008898) HLA-B27 [Presence]

856

1.15

0.66

1.1

—

(3020491) Glucose [Moles/volume] in Blood

206

1.31

0.65

1.6

2.0

7.05

6.93

mmol/l

0.07

139

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

433

1.20

0.62

1.8

1.6

—

(4015189) Microbial culture of sputum

1.55

0.62

1.5

2.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.59

0.61

1.8

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

1.82

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.54

0.59

1.8

2.3

15.13

17.26

umol/l

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.06

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

225

2433

0.92

0.59

2.5

2.3

12.73

12.89

nmol/l

0.09

196

2171

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

0.03

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.2

—

11.17

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

383

1.20

0.57

1.4

1.5

0.20

0.36

nmol/l

3.60

307

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

111

991

1.12

0.57

1.7

1.6

32.55

18.02

u/ml

0.71

215

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

133

1.36

0.55

3.4

1.8

2.02

754.51

pmol/l

—

(40768793) Breast Pathology biopsy report

570

1.14

0.46

1.2

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.37

0.43

3.1

2.3

16.73

102.69

ug/l

0.52

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

275

1.20

0.43

1.9

1.5

2.10

3.27

ug/l

1.04

242

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.61

0.43

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

396

1.16

0.42

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

627

0.88

0.42

1.5

—

(3013637) Mi-2 Ab [Presence] in Serum

0.63

0.42

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.63

0.42

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.63

0.42

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.63

0.42

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.2

—

0.23

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

39.03

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

5.24

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

123

1.30

0.40

1.1

1.2

12.63

9.40

mm/h

0.33

123

(3026051) Granulocytes/Leukocytes in Pleural fluid

1.41

0.39

2.2

1.3

23.00

22.55

—

(4094501) Cardiovascular stress test using bicycle ergometer

748

0.89

0.38

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

557

0.88

0.37

1.6

1.5

75.85

61.33

ug/l

1.24

467

(3011897) Casein IgE Ab [Units/volume] in Serum

1.40

0.35

1.0

1.5

0.02

3.00

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

633

1.11

0.34

6.6

3.7

32.69

28.04

mg/l

0.56

453

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

360

1.14

0.32

1.1

—

(4146454) Self-monitoring of blood glucose

316

0.85

0.31

2.9

2.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.27

0.30

2.0

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.27

0.30

2.0

2.2

—

(3005033) Fetal Nuchal fold Thickness US

420

0.88

0.29

1.6

1.5

1.30

1.28

0.06

295

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

149

1.21

0.27

2.3

1.6

3.38

2.48

u/field

0.16

110

(40765089) Chromosome analysis panel - Blood by G-banded

1.25

0.27

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

117

0.77

0.27

1.4

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

234

1.16

0.26

3.1

3.2

218.99

29.34

mg/l

0.72

180

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

373

0.88

0.26

2.0

2.3

15.82

21.16

mg/l

0.93

135

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

924

0.93

0.26

2.2

1.7

10.88

4.41

mg/l

1.54

687

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

244

1.15

0.25

1.4

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

179

1.17

0.25

1.3

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

507

0.91

0.24

1.6

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

331

1.12

0.24

1.1

3.53

4.86

u/ml

0.34

151

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

152

1.19

0.23

2.3

2.1

278.00

123.45

ug/min

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

447

1.10

0.23

1.0

1.1

5.40

4.88

u/ml

0.09

243

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.74

0.22

1.3

1.5

32.51

34.52

nmol/l

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

116

1.21

0.22

3.6

1.8

40.74

39.78

g/l

0.32

116

(3047352) Trisomy 18 risk [Likelihood] in Fetus

430

0.91

0.21

1.6

1.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.89

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.12

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.92

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.21

0.0

1.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

136

1.18

0.20

1.1

1.2

0.62

3.18

u/ml

—

(3033099) Centromere Ab [Titer] in Serum

1.22

0.20

1.5

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.20

0.19

2.7

6.8

8.80

8.64

mmol/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

174

1.15

0.19

1.4

168.29

158.84

pmol/l

0.14

174

(3010726) Horse dander IgE Ab [Units/volume] in Serum

423

1.09

0.19

1.1

1.09

1.32

u/ml

0.19

227

(3013139) Helicobacter pylori Ag [Presence] in Stool

189

1823

1.04

0.18

1.3

—

(3000492) Spirometry study

268

2602

1.03

0.18

1.7

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

436

1.08

0.17

1.0

1.1

0.73

1.37

u/ml

0.70

195

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

516

0.93

0.17

1.5

1.24

1.17

ratio

0.22

320

(3041806) Other cells [#/volume] in Blood by Manual count

0.72

0.17

1.4

1.5

0.62

0.48

e9/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

129

0.85

0.14

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

440

0.93

0.14

1.6

1.5

—

(3006462) Nitrate [Presence] in Urine

118

0.85

0.14

2.1

3.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2513

25218

0.99

0.13

37.3

17.0

75.59

78.50

ml/min/173m2

6.85

2413

23464

(3015076) Soybean IgE Ab [Units/volume] in Serum

114

1.14

0.11

1.0

1.1

0.73

1.25

u/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

259

1.08

0.11

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

516

0.95

0.11

1.5

0.93

0.96

ratio

0.28

320

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

516

0.95

0.11

1.5

1.21

1.19

ratio

0.04

320

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2463

24552

1.01

0.11

6.0

5.3

2.00

1.94

mu/l

1.11

2340

22621

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

321

0.93

0.10

1.0

1.1

0.30

0.20

u/ml

0.22

114

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2760

27664

0.99

0.10

23.6

12.2

26.85

25.88

u/l

0.44

2715

26826

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.14

0.10

1.0

1.2

—

(44813793) Dust mix specific IgE antibody measurement

164

1.10

0.09

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

517

1.05

0.09

1.0

1.1

2.95

2.16

u/ml

0.19

286

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.05

0.08

1.0

9.40

43.75

iu/ml

—

(3022689) Creatine [Moles/volume] in Urine

1.04

0.07

1.6

1.4

5.06

8.08

mmol/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2809

28049

1.01

0.06

48.3

22.7

97.62

80.69

umol/l

24.03

2773

27703

(4211845) Urine protein measurement

131

0.92

0.05

2.3

3.2

—

(3020650) Glucose [Presence] in Urine

100

1.10

0.05

1.4

2.0

0.00

0.06

estimate

0.80

100

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

169

1.07

0.05

1.8

1.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

248

1.05

0.05

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

130

1.08

0.04

1.0

1.1

0.58

27.87

u/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

129

0.93

0.03

1.2

1.3

—

(3045424) Erythrocytes [Presence] in Urine

141

1424

0.99

0.02

3.5

2.2

0.00

0.60

estimate

0.51

424

(1002224) Polysomnography panel

116

1166

0.99

0.00

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

138

1.01

0.00

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

769

1.00

0.00

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

151

0.99

0.00

4.2

3.5

32.34

26.73

mu/l

0.24

145

(3014133) Dog dander IgE Ab [Units/volume] in Serum

356

1.01

0.00

1.1

1.60

3.45

u/ml

1.32

181

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

147

1.02

0.00

5.2

7.1

12.33

139.43

ug/l

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

2.20

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

9.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

320

1.00

-0.00

1.3

7.50

7.41

mmol/l

0.05

278

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.99

-0.00

2.1

1.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.96

-0.00

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

26.50

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_OTHER_INFECTIONS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_OTHER_INFECTIONS	2.899 [2.57, 3.27]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.203

During the follow-up period (1.1.1998 — 31.12.2019), 5152 out of 11728 females with AB1_OTHER_INFECTIONS died.

Males

Parameter	HR [95% CI]	p-value
AB1_OTHER_INFECTIONS	3.052 [2.66, 3.49]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 5986 out of 12760 males with AB1_OTHER_INFECTIONS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_OTHER_INFECTIONS.

N-year risk	Females	Males
1	0.244%	0.699%
5	1.528%	3.358%
10	4.186%	7.93%
15	8.183%	15.529%
20	14.109%	25.974%

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_INFECTIONS – Other infectious diseases

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other infectious diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints